2025/04/30 更新

写真a

ミヤザキ トモユキ
宮﨑 智之
Tomoyuki Miyazaki
所属
研究・産学連携推進センター 教授
職名
教授
プロフィール

若者の生きづらさを解消する産官学連携での取り組みを進めています(JST 共創の場形成支援プログラム プロジェクトリーダー)。

また世界に先駆けてAMPA受容体認識PET薬剤の開発に成功し、精神・神経疾患のメカニズム解明等に資する研究を展開しています。

外部リンク

学位

  • 医学博士 ( 2012年3月   横浜市立大学 )

研究キーワード

  • 慢性疼痛

  • PET薬剤開発

  • AMPA受容体

  • 麻酔メカニズム

  • 行動薬理

研究分野

  • ライフサイエンス / 生理学

  • ライフサイエンス / 神経科学一般

  • ライフサイエンス / 麻酔科学

  • ライフサイエンス / 医療薬学

経歴

  • 横浜市立大学   学長補佐

    2023年4月 - 現在

      詳細を見る

  • 横浜市立大学 研究・産学連携推進センター   拠点事業推進部門   部門長 教授

    2023年4月 - 現在

      詳細を見る

  • 横浜市立大学医学部   医学部生理学 麻酔科学(併任)

    2023年1月 - 現在

      詳細を見る

  • 横浜市立大学   研究・産学連携推進センター 拠点事業推進部門   准教授

    2023年1月 - 2023年3月

      詳細を見る

  • 横浜市立大学附属病院   次世代臨床研究センター   相談役

    2021年11月 - 現在

      詳細を見る

  • 横浜市立大学医学部   生理学/麻酔科学   准教授

    2016年4月 - 2022年12月

      詳細を見る

  • 横浜市立大学医学部生   生理学/麻酔科学   助教

    2012年5月 - 2016年3月

      詳細を見る

  • 横浜市立大学医学部   生理学   助手

    2010年4月 - 2012年4月

      詳細を見る

  • 横浜市立大学医学研究科   博士課程

    2006年4月 - 2010年3月

      詳細を見る

  • 藤沢市民病院   麻酔科医

    2006年4月 - 2007年3月

      詳細を見る

  • 横浜市立大学附属病院   臨床研修医

    2004年4月 - 2006年3月

      詳細を見る

  • 横浜市立大学医学部

    1998年4月 - 2004年3月

      詳細を見る

▼全件表示

所属学協会

委員歴

  • 日本薬理学会   学術評議員  

    2022年4月 - 現在   

      詳細を見る

  • 日本麻酔科学会   神経ワーキンググループメンバー  

    2020年4月 - 現在   

      詳細を見る

  • 特許庁   医薬バイオ創業期ワーキンググループメンバー  

    2019年4月 - 2020年3月   

      詳細を見る

論文

  • Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography

    Mai Hatano, Waki Nakajima, Hideaki Tani, Hiroyuki Uchida, Tomoyuki Miyazaki, Tetsu Arisawa, Yuuki Takada, Sakiko Tsugawa, Akane Sano, Kotaro Nakano, Tsuyoshi Eiro, Hiroki Abe, Akira Suda, Takeshi Asami, Akitoyo Hishimoto, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Shunya Kurokawa, Yohei Ohtani, Kie Takahashi, Yuhei Kikuchi, Taisuke Yatomi, Shiori Honda, Masahiro Jinzaki, Yoji Hirano, Ryo Mitoma, Shunsuke Tamura, Shingo Baba, Osamu Togao, Hirotaka Kosaka, Hidehiko Okazawa, Yuichi Kimura, Masaru Mimura, Takuya Takahashi

    Molecular Psychiatry   2024年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    Synaptic phenotypes in living patients with psychiatric disorders are poorly characterized. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a fundamental component for neurotransmission. We recently developed a positron emission tomography (PET) tracer for AMPAR, [<sup>11</sup>C]K-2, the first technology to visualize and quantify AMPARs density in living human brain. In this study, we characterized patients with major psychiatric disorders with [<sup>11</sup>C]K-2. One hundred forty-nine patients with psychiatric disorders (schizophrenia, n = 42; bipolar disorder, n = 37; depression, n = 35; and autism spectrum disorder, n = 35) and 70 healthy participants underwent a PET scan with [<sup>11</sup>C]K-2 for measurement of AMPAR density. We detected brain regions that showed correlation between AMPAR density and symptomatology scores in each of four disorders. We also found brain areas with significant differences in AMPAR density between patients with each psychiatric disorder and healthy participants. Some of these areas were observed across diseases, indicating that these are commonly affected areas throughout psychiatric disorders. Schizophrenia, bipolar disorder, depression, and autism spectrum disorder are uniquely characterized by AMPAR distribution patterns. Our approach to psychiatric disorders using [<sup>11</sup>C]K-2 can elucidate the biological mechanisms across diseases and pave the way to develop novel diagnostics and therapeutics based on the synapse physiology.

    DOI: 10.1038/s41380-024-02785-1

    researchmap

    その他リンク: https://www.nature.com/articles/s41380-024-02785-1

  • Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial. 国際誌

    Yohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, Taisuke Yatomi, Kengo Yonezawa, Sota Tomiyama, Nobuhiro Nagai, Keisuke Kusudo, Shiori Honda, Sotaro Moriyama, Shinichiro Nakajima, Takashige Yamada, Hiroshi Morisaki, Yu Iwabuchi, Masahiro Jinzaki, Kimio Yoshimura, Tsuyoshi Eiro, Sakiko Tsugawa, Sadamitsu Ichijo, Yu Fujimoto, Tomoyuki Miyazaki, Takuya Takahashi, Hiroyuki Uchida

    Psychiatry and clinical neurosciences   2024年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: Although the antidepressant effect of ketamine on treatment-resistant depression (TRD) has been frequently reported in North American and European countries, evidence is scarce among the Asian population. We aimed to evaluate the efficacy and safety of intravenous ketamine in Japanese patients with TRD. METHODS: In this double-blind randomized placebo-controlled trial, 34 Japanese patients with TRD were randomized to receive either intravenous ketamine (0.5 mg/kg) or placebo, administered over 40 min, twice a week, for 2 weeks. The primary outcome was the change in the Montgomery Åsberg Depression Rating Scale (MADRS) total score from baseline to post-treatment. Secondary outcomes included changes in other depressive symptomatology scores and remission, response, and partial response rates. We also examined the association between baseline clinical demographic characteristics and changes in the MADRS total score. RESULTS: Intention-to-treat analysis indicated no significant difference in the decrease in MADRS total score between the groups (-8.1 ± 10.0 vs -2.5 ± 5.2, t[32] = 2.02, P = 0.052), whereas per-protocol analysis showed a significant reduction in the ketamine group compared to the placebo group (-9.1 ± 10.2 vs -2.7 ± 5.3, t[29] = 2.22, P = 0.034). No significant group differences were observed in other outcomes. Adverse events were more frequent in the ketamine group than in the placebo group, and no serious adverse events were reported. A higher baseline MADRS total score and body mass index were associated with a greater reduction in the MADRS total score. CONCLUSION: Intravenous ketamine outperformed placebo in Japanese patients with TRD who completed the study, suggesting that ketamine could alleviate depressive symptoms of TRD across diverse ethnic populations.

    DOI: 10.1111/pcn.13734

    PubMed

    researchmap

  • Enhancement of Haloperidol-Induced Catalepsy by GPR143, an L-Dopa Receptor, in Striatal Cholinergic Interneurons. 国際誌

    Masami Arai, Etsuko Suzuki, Satoshi Kitamura, Momoyo Otaki, Kaori Kanai, Miwako Yamasaki, Masahiko Watanabe, Yuki Kambe, Koshi Murata, Yuuki Takada, Tetsu Arisawa, Kenta Kobayashi, Rei Tajika, Tomoyuki Miyazaki, Masahiro Yamaguchi, Michael Lazarus, Yu Hayashi, Shigeyoshi Itohara, Alban de Kerchove d'Exaerde, Hiroyuki Nawa, Ryang Kim, Haruhiko Bito, Toshihiko Momiyama, Daiki Masukawa, Yoshio Goshima

    The Journal of neuroscience : the official journal of the Society for Neuroscience   44 ( 11 )   2024年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Dopamine neurons play crucial roles in pleasure, reward, memory, learning, and fine motor skills and their dysfunction is associated with various neuropsychiatric diseases. Dopamine receptors are the main target of treatment for neurologic and psychiatric disorders. Antipsychotics that antagonize the dopamine D2 receptor (DRD2) are used to alleviate the symptoms of these disorders but may also sometimes cause disabling side effects such as parkinsonism (catalepsy in rodents). Here we show that GPR143, a G-protein-coupled receptor for L-3,4-dihydroxyphenylalanine (L-DOPA), expressed in striatal cholinergic interneurons enhances the DRD2-mediated side effects of haloperidol, an antipsychotic agent. Haloperidol-induced catalepsy was attenuated in male Gpr143 gene-deficient (Gpr143-/y ) mice compared with wild-type (Wt) mice. Reducing the endogenous release of L-DOPA and preventing interactions between GPR143 and DRD2 suppressed the haloperidol-induced catalepsy in Wt mice but not Gpr143-/y mice. The phenotypic defect in Gpr143-/y mice was mimicked in cholinergic interneuron-specific Gpr143-/y (Chat-cre;Gpr143flox/y ) mice. Administration of haloperidol increased the phosphorylation of ribosomal protein S6 at Ser240/244 in the dorsolateral striatum of Wt mice but not Chat-cre;Gpr143flox/y mice. In Chinese hamster ovary cells stably expressing DRD2, co-expression of GPR143 increased cell surface expression level of DRD2, and L-DOPA application further enhanced the DRD2 surface expression. Shorter pauses in cholinergic interneuron firing activity were observed after intrastriatal stimulation in striatal slice preparations from Chat-cre;Gpr143flox/y mice compared with those from Wt mice. Together, these findings provide evidence that GPR143 regulates DRD2 function in cholinergic interneurons and may be involved in parkinsonism induced by antipsychotic drugs.

    DOI: 10.1523/JNEUROSCI.1504-23.2024

    PubMed

    researchmap

  • Anti-epileptic drug use and subsequent degenerative dementia occurrence. 国際誌

    Naoki Ikegaya, Honoka Nakamura, Yutaro Takayama, Yohei Miyake, Takahiro Hayashi, Masaki Sonoda, Mitsuru Sato, Kensuke Tateishi, Jun Suenaga, Masao Takaishi, Yu Kitazawa, Misako Kunii, Hiroki Abe, Tomoyuki Miyazaki, Tetsuaki Arai, Manabu Iwasaki, Takayuki Abe, Tetsuya Yamamoto

    Alzheimer's & dementia (New York, N. Y.)   10 ( 3 )   e70001   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: The use of anti-epileptic drugs (AEDs) in degenerative dementia (DD) remains uncertain. We aimed to evaluate the association of early AED administration with subsequent DD occurrence. METHODS: Using a large nationwide database, we enrolled patients newly diagnosed with epilepsy from 2014 to 2019 (n = 104,225), and using propensity score matching, we divided them into treatment (those prescribed AEDs in 2014) and control groups. The primary outcome was subsequent DD occurrence in 2019. RESULTS: Overall, 4489 pairs of patients (2156 women) were matched. The odds ratio (treatment/control) for DD occurrence was 0.533 (95% confidence interval: 0.459-0.617). The DD proportions significantly differed between the treatment (340/4489 = 0.076) and control (577/4489 = 0.129) groups. DISCUSSION: Among patients newly diagnosed with epilepsy, compared to non-use, early AED use was associated with a lower occurrence of subsequent DD. Further investigations into and optimization of early intervention for epilepsy in DD are warranted. HIGHLIGHTS: Anti-epileptic drug (AED) use before epilepsy diagnosis was linked with a lower subsequent degenerative dementia (DD) occurrence.Identifying the epileptic phenotype was crucial for justifying early AED use in DD.AED use with an epilepsy diagnosis did not pose an additional risk of DD.The potential contribution of combination drug therapy to the strategy was noted.

    DOI: 10.1002/trc2.70001

    PubMed

    researchmap

  • Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertension. 国際誌

    Mari Sotozawa, Sho Kinguchi, Hiromichi Wakui, Kengo Azushima, Kengo Funakoshi, Waki Nakajima, Tomoyuki Miyazaki, Takuya Takahashi, Kouichi Tamura

    Hypertension research : official journal of the Japanese Society of Hypertension   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The renin-angiotensin system in the brain plays a pivotal role in modulating sympathetic nerve activity and contributes to the pathogenesis of hypertension. Angiotensin II (Ang II) type 1 receptor (AT1R)-associated protein (ATRAP) promotes internalization of AT1R while suppressing pathological overactivation of AT1R signaling. However, the pathophysiological function of ATRAP in the brain remains unknown. Therefore, this study aims to investigate whether ATRAP in the paraventricular nucleus (PVN) is involved in neurogenic hypertension pathogenesis in Ang II-infused rats. The ATRAP/AT1R ratio, which serves as an indicator of tissue AT1R hyperactivity, tended to decrease within the PVN in the Ang II group than in the vehicle group. This suggests an Ang II-induced hyperactivation of the AT1R signaling pathway in the PVN. Lentiviral vectors were generated to stimulate ATRAP expression. At 6 weeks of age, rats were microinjected with LV-Venus (Venus-expressing lentivirus) or LV-ATRAP (Venus-ATRAP-expressing lentivirus). The rats were then randomly divided into four groups: (1) Vehicle/LV-Venus, (2) Vehicle/LV-ATRAP, (3) Ang II/LV-Venus, and (4) Ang II/LV-ATRAP. Two weeks after microinjection, vehicle or Ang II was administered systemically for 2 weeks. In the Ang II/LV-ATRAP group, systolic blood pressure at 1 and 2 weeks following administration was significantly lower than that in the Ang II/LV-Venus group. Furthermore, urinary adrenaline levels tended to decrease in the Ang II/LV-ATRAP group than in the Ang II/LV-Venus group. These findings suggest that enhanced ATRAP expression in the PVN suppresses Ang II-induced hypertension, potentially by suppressing hyperactivation of the tissue AT1R signaling pathway and, subsequently, sympathetic nerve activity.

    DOI: 10.1038/s41440-023-01480-y

    PubMed

    researchmap

  • てんかん病態を制御する脳内AMPA受容体の動態

    永露 毅, 宮崎 智之, 波多野 真依, 中島 和希, 有澤 哲, 高田 由貴, 木村 キミト, 野田 賀大, 内田 裕之, 木村 裕一, 高橋 琢哉

    核医学技術   43 ( 予稿集 )   321 - 321   2023年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本核医学技術学会  

    researchmap

  • AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines. 国際誌

    Nami Masumoto, Shingo Kato, Masahiro Aichi, Sho Hasegawa, Kota Sahara, Kumiko Suyama, Akane Sano, Tomoyuki Miyazaki, Koji Okudela, Takeshi Kaneko, Takuya Takahashi

    Thoracic cancer   14 ( 29 )   2897 - 2908   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Small cell lung cancer (SCLC) is a neuroendocrine tumor with poor prognosis. Neuroendocrine tumors possess characteristics of both nerve cells and hormone-secreting cells; therefore, targeting the neuronal properties of these tumors may lead to the development of new therapeutic options. Among the endogenous signaling pathways in the nervous system, targeting the glutamate pathway may be a useful strategy for glioblastoma treatment. Perampanel, an antagonist of the synaptic glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR), has been reported to be effective in patients with glioblastoma. In this study, we aimed to investigate the antitumor effects of AMPAR antagonists in human SCLC cell lines. METHODS: We performed to examine the expression of AMPAR using Western blot and immunohistochemical analysis. The antitumor effects of AMPAR antagonists on human SCLC cell lines were investigated in vitro and in vivo. We also analyzed the signaling pathway of AMPAR antagonists in SCLC cell lines. Statistical analysis was performed by the GraphPad Prism 6 software. RESULTS: We first examined the expression of endogenous AMPAR in six human SCLC cell lines, detecting AMPAR proteins in all of them. Next, we tested the anti-proliferative effect of two AMPAR antagonists, talampanel and cyanquixaline, using SCLC cells in vitro and in vivo. Both AMPAR antagonists inhibited cell proliferation and mitogen-activated protein kinase (MAPK) phosphorylation in SCLC cells in vitro. Further, we observed reduced proliferation of implanted cell lines in an in vivo setting, assessed by Ki-67 immunohistochemistry. Additionally, using immunohistochemical analysis we confirmed AMPAR protein expression in human SCLC samples. CONCLUSION: AMPAR may be a potential therapeutic target for SCLC.

    DOI: 10.1111/1759-7714.15075

    PubMed

    researchmap

  • フレキシブル薄膜電極を用いた難治てんかんに対する診断・治療機器開発とその展望

    園田 真樹, 藤枝 俊宣, 宮下 英三, 今井 綾乃, 伊勢 真由子, 関田 大生, 林 貴啓, 高山 裕太郎, 宮崎 智之, 山本 哲哉

    てんかん研究   41 ( 2 )   394 - 394   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • セボフルランの位相振幅カップリング増強効果を用いたてんかん原性領域の局在化

    園田 真樹, 和田 圭伊子, Firestone Ethan, 坂倉 和樹, 黒田 直生人, 高山 裕太郎, 飯島 圭哉, 岩崎 真樹, 水原 敬洋, 山本 哲哉, 後藤 隆久, 浅野 英司, 宮崎 智之

    てんかん研究   41 ( 2 )   413 - 413   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • IDH1変異グリオーママウスモデルにおける変異型IDH1阻害剤のてんかん抑制効果の検討

    林 貴啓, 立石 健祐, 池谷 直樹, 園田 真樹, 高山 裕太郎, 宮崎 智之, 中島 和希, 山本 哲哉

    てんかん研究   41 ( 2 )   440 - 440   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy. 国際誌

    Tsuyoshi Eiro, Tomoyuki Miyazaki, Mai Hatano, Waki Nakajima, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Akane Sano, Kotaro Nakano, Takahiro Mihara, Yutaro Takayama, Naoki Ikegaya, Masaki Iwasaki, Akitoyo Hishimoto, Yoshihiro Noda, Takahiro Miyazaki, Hiroyuki Uchida, Hideaki Tani, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Masaru Mimura, Nozomu Matsuda, Kazuaki Kanai, Kazuhiro Takahashi, Hiroshi Ito, Yoji Hirano, Yuichi Kimura, Riki Matsumoto, Akio Ikeda, Takuya Takahashi

    Cell reports. Medicine   4 ( 5 )   101020 - 101020   2023年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) contribute to epileptogenesis. Thirty patients with epilepsy and 31 healthy controls are scanned using positron emission tomography with our recently developed radiotracer for AMPARs, [11C]K-2, which measures the density of cell-surface AMPARs. In patients with focal-onset seizures, an increase in AMPAR trafficking augments the amplitude of abnormal gamma activity detected by electroencephalography. In contrast, patients with generalized-onset seizures exhibit a decrease in AMPARs coupled with increased amplitude of abnormal gamma activity. Patients with epilepsy had reduced AMPAR levels compared with healthy controls, and AMPARs are reduced in larger areas of the cortex in patients with generalized-onset seizures compared with those with focal-onset seizures. Thus, epileptic brain function can be regulated by the enhanced trafficking of AMPAR due to Hebbian plasticity with increased simultaneous neuronal firing and compensational downregulation of cell-surface AMPARs by the synaptic scaling.

    DOI: 10.1016/j.xcrm.2023.101020

    PubMed

    researchmap

  • Sevoflurane-induced high-frequency oscillations, effective connectivity and intraoperative classification of epileptic brain areas. 国際誌

    Ethan Firestone, Masaki Sonoda, Naoto Kuroda, Kazuki Sakakura, Jeong-Won Jeong, Min-Hee Lee, Keiko Wada, Yutaro Takayama, Keiya Iijima, Masaki Iwasaki, Tomoyuki Miyazaki, Eishi Asano

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology   150   17 - 30   2023年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To determine how sevoflurane anesthesia modulates intraoperative epilepsy biomarkers on electrocorticography, including high-frequency oscillation (HFO) effective connectivity (EC), and to investigate their relation to epileptogenicity and anatomical white matter. METHODS: We studied eight pediatric drug-resistant focal epilepsy patients who achieved seizure control after invasive monitoring and resective surgery. We visualized spatial distributions of the electrocorticography biomarkers at an oxygen baseline, three time-points while sevoflurane was increasing, and at a plateau of 2 minimum alveolar concentration (MAC) sevoflurane. HFO EC was combined with diffusion-weighted imaging, in dynamic tractography. RESULTS: Intraoperative HFO EC diffusely increased as a function of sevoflurane concentration, although most in epileptogenic sites (defined as those included in the resection); their ability to classify epileptogenicity was optimized at sevoflurane 2 MAC. HFO EC could be visualized on major white matter tracts, as a function of sevoflurane level. CONCLUSIONS: The results strengthened the hypothesis that sevoflurane-activated HFO biomarkers may help intraoperatively localize the epileptogenic zone. SIGNIFICANCE: Our results help characterize how HFOs at non-epileptogenic and epileptogenic networks respond to sevoflurane. It may be warranted to establish a normative HFO atlas incorporating the modifying effects of sevoflurane and major white matter pathways, as critical reference in epilepsy presurgical evaluation.

    DOI: 10.1016/j.clinph.2023.03.004

    PubMed

    researchmap

  • Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum. 国際誌

    Daiki Masukawa, Satoshi Kitamura, Rei Tajika, Hiraku Uchimura, Masami Arai, Yuuki Takada, Tetsu Arisawa, Momoyo Otaki, Kaori Kanai, Kenta Kobayashi, Tomoyuki Miyazaki, Yoshio Goshima

    Journal of neurochemistry   2023年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Dopamine (DA) is involved in neurological and physiological functions such as motor control. L-3,4-dihydroxyphenylalanine (L-DOPA), a precursor of DA is conventionally believed to be an inert amino acid precursor of DA, and its major therapeutic effects in Parkinson's disease (PD) are mediated through its conversion to DA. On the contrary, accumulating evidence suggests that L-DOPA itself is a neurotransmitter. We here show that L-DOPA potentiates DA D2 receptor (DRD2) signaling through GPR143, the gene product of X-linked ocular albinism 1, a G protein-coupled receptor for L-DOPA. In Gpr143 gene-deficient (Gpr143-/y ) mice, quinpirole, a DRD2/DRD3 agonist, -induced hypolocomotion was attenuated compared to wild-type (WT) mice. Administration of non-effective dose of L-DOPA methyl ester augmented the quinpirole-induced hypolocomotion in WT mice but not in Gpr143-/y mice. In cells co-expressing GPR143 and DRD2, L-DOPA enhanced the interaction between GPR143 and DRD2, and augmented quinpirole-induced decrease in cAMP levels. These augmentation by L-DOPA was not observed in cells co-expressing GPR143 and DRD1 or DRD3. Chimeric analysis in which the domain of GPR143 was replaced with GPR37 revealed that GPR143 interacted with DRD2 at the fifth transmembrane domain. Intracerebroventricular administration of a peptide that disrupted the interaction mitigated quinpirole-induced behavioral changes in WT mice but not in Gpr143-/y mice. These findings provide evidence that coupling between GPR143 and DRD2 is required for selective DRD2 modulation by L-DOPA in the dorsal striatum.

    DOI: 10.1111/jnc.15789

    PubMed

    researchmap

  • Synthesis of [F-18] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors

    Tetsu Arisawa, Kimito Kimura, Tomoyuki Miyazaki, Yuuki Takada, Waki Nakajima, Wataru Ota, Sadamitsu Ichijo, Akane Sano, Yuuka Hirao, Jun-ichi Kurita, Yoshifumi Nishimura, Takuya Takahashi

    NUCLEAR MEDICINE AND BIOLOGY   110   47 - 58   2022年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE INC  

    Introduction: AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) receptors play a central role in neurotransmission and neuronal function. A positron emission tomography (PET) tracer for AMPA re-ceptors, [C-11]K-2, was recently developed by us to visualize AMPA receptors in the living human brain. [C-11]K-2 is a derivative of 4-[2-(phenylsulphonylamino)ethylthio]-2,6-difuluoro-phenoxyacetamide (PEPA), and is labeled with the radioactive isotope C-11, which has a short half-life. PET drugs are usually labeled with F-18 because of its long half-life. Therefore, we screened and identified potential F-18-labeled PET drugs for AMPA receptors (AMPA-PET drugs), which could provide an image equivalent to that of [C-11]K-2. Methods: Derivatives of K-2 labeled with F-18 were synthesized and administered to rats and PET imaging was performed. The transferability of each compound to the brain and its correlation with the PET image of [C-11]K-2 were evaluated from the obtained PET images. Furthermore, the specific binding ability of promising compounds to the AMPA receptor was evaluated by the PET imaging of rats, which we specifically knocked down the expression of AMPA by the lentivirus-mediated introduction of short hairpin RNA (shRNA) targeted to subunits of the AMPA receptor (GluA1-A3). The specific binding ability was also evaluated through electrophysiological experiments with acute brain slices. Results: Some of the synthesized F-18-labeled candidate compounds showed a distribution similar to that of K-2, with reasonable transferability to the brain. In addition, from the evaluation of the specific binding ability to the AMPA receptor, a promising structure of an 18F-labeled AMPA PET drug was identified. This study also revealed that the alkylation of the sulfonamide group of PEPA enhances brain transferability.

    DOI: 10.1016/j.nucmedbio.2022.04.009

    Web of Science

    researchmap

  • Assessments of prolonged effects of desflurane and sevoflurane on motor learning deficits in aged AppNL-G-F/NL-G-F mice. 国際誌

    Ryo Niikura, Tomoyuki Miyazaki, Kenkichi Takase, Hiroki Sasaguri, Takashi Saito, Takaomi C Saido, Takahisa Goto

    Molecular brain   15 ( 1 )   32 - 32   2022年4月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    As the proportion of elderly in society increases, so do the number of older patients undergoing surgical procedures. This is concerning as exposure to anesthesia has been identified as a risk factor for Alzheimer's disease (AD). However, the causal relationship between clinical AD development and anesthesia remains conjectural. Preclinical studies have demonstrated that anesthesia, such as halothane, isoflurane, and sevoflurane, induces AD-like pathophysiological changes and cognitive impairments in transgenic mouse models of AD. Desflurane does not have these effects and is expected to have more potential for use in elderly patients, yet little is known about its effects, especially on non-cognitive functions, such as motor and emotional functions. Thus, we examined the postanesthetic effects of desflurane and sevoflurane on motor and emotional function in aged AppNL-G-F/NL-G-F (App-KI) mice. This is a recently developed transgenic mouse model of AD exhibiting amyloid β peptide (Aβ) amyloidosis and a neuroinflammatory response in an age-dependent manner without non-physiological amyloid precursor protein (APP) overexpression. Mice were subjected to a short behavioral test battery consisting of an elevated plus maze, a balance beam test, and a tail suspension test seven days after exposure to 8.0% desflurane for 6 h or 2.8% sevoflurane for 2 h. App-KI mice showed significant increments in the percentage of entry and time spent in open arms in the elevated plus maze, increments in the number of slips and latency to traverse for the balance beam test, increments in the limb clasping score, increments in immobile duration, and decrements in latency to first immobile episode for the tail suspension test compared to age-matched wild type (WT) controls. Desflurane- and sevoflurane-exposed App-KI mice showed a delayed decrement in the number of slips for each trial in the balance beam test, while air-treated App-KI mice rapidly improved their performance, and increased their clasping behavior in the tail suspension test. Furthermore, App-KI inhibited the change in membrane GluA3 following exposure to anesthetics in the cerebellum. These results suggest high validity of App-KI mice as an animal model of AD.

    DOI: 10.1186/s13041-022-00910-1

    PubMed

    researchmap

  • AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. 国際誌

    Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Nobuhiro Nagai, Teruki Koizumi, Tomoyuki Miyazaki, Masaru Mimura, Takuya Takahashi, Hiroyuki Uchida

    Schizophrenia research   243   98 - 109   2022年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: While altered expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type receptor has been reported in postmortem studies of schizophrenia, these findings are inconsistent. Therefore, we aimed to systematically review postmortem studies that investigated AMPA receptor expressions in schizophrenia. METHODS: A systematic literature search was conducted for postmortem studies that measured AMPA receptor subunit expressions or receptor bindings in schizophrenia compared to healthy individuals on February 3, 2021, using Medline and Embase. RESULTS: A total of 39 relevant articles were identified from 1360 initial reports. The dorsolateral prefrontal cortex (DLPFC) was the most investigated region (15 studies), followed by the medial temporal lobe (8 studies). For the DLPFC, 4/15 studies (26.7%) showed increased AMPA receptor binding or subunit expression in patients with schizophrenia compared to that in controls, especially in GRIA1 and GRIA4, 2/15 studies (13.3%) reported a decrease, particularly in GRIA2, and 8/15 studies (56.7%) found no significant differences. A decreased expression or receptor binding was observed in 6/8 studies (75.0%) in the subregions of the hippocampus in patients with schizophrenia compared to that in controls, whereas the other two studies found no significant differences. CONCLUSION: Published data have reported decreased subunit expression or receptor binding in the hippocampus in schizophrenia. These findings were inconsistent in other brain regions, which might be due to the heterogeneity of this population, various study design, physiological changes after death, and limited number of studies. Future in vivo studies are warranted to examine AMPA receptor expressions in human brains, together with their comprehensive clinical characterization.

    DOI: 10.1016/j.schres.2022.02.033

    PubMed

    researchmap

  • Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone. 国際誌

    Keiko Wada, Masaki Sonoda, Ethan Firestone, Kazuki Sakakura, Naoto Kuroda, Yutaro Takayama, Keiya Iijima, Masaki Iwasaki, Takahiro Mihara, Takahisa Goto, Eishi Asano, Tomoyuki Miyazaki

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology   134   1 - 8   2022年2月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Phase-amplitude coupling between high-frequency (≥150 Hz) and delta (3-4 Hz) oscillations - modulation index (MI) - is a promising, objective biomarker of epileptogenicity. We determined whether sevoflurane anesthesia preferentially enhances this metric within the epileptogenic zone. METHODS: This is an observational study of intraoperative electrocorticography data from 621 electrodes chronically implanted into eight patients with drug-resistant, focal epilepsy. All patients were anesthetized with sevoflurane during resective surgery, which subsequently resulted in seizure control. We classified 'removed' and 'retained' brain sites as epileptogenic and non-epileptogenic, respectively. Mixed model analysis determined which anesthetic stage optimized MI-based classification of epileptogenic sites. RESULTS: MI increased as a function of anesthetic stage, ranging from baseline (i.e., oxygen alone) to 2.0 minimum alveolar concentration (MAC) of sevoflurane, preferentially at sites showing higher initial MI values. This phenomenon was accentuated just prior to sevoflurane reaching 2.0 MAC, at which time, the odds of a site being classified as epileptogenic were enhanced by 86.6 times for every increase of 1.0 MI. CONCLUSIONS: Intraoperative MI best localized the epileptogenic zone immediately before sevoflurane reaching 2.0 MAC in this small cohort of patients. SIGNIFICANCE: Prospective, large cohort studies are warranted to determine whether sevoflurane anesthesia can reduce the need for extraoperative, invasive evaluation.

    DOI: 10.1016/j.clinph.2021.11.004

    PubMed

    researchmap

  • Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptor.

    Masayuki Nakano, Motokazu Koga, Tatsuo Hashimoto, Natsuki Matsushita, Daiki Masukawa, Yusuke Mizuno, Hiraku Uchimura, Ryo Niikura, Tomoyuki Miyazaki, Fumio Nakamura, Suo Zou, Takahiro Shimizu, Motoaki Saito, Kouichi Tamura, Takahisa Goto, Yoshio Goshima

    Journal of pharmacological sciences   148 ( 2 )   214 - 220   2022年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Pulmonary hypertension (PH) is a severe and progressive disease that causes elevated right ventricular systolic pressure, right ventricular hypertrophy and ultimately right heart failure. However, the underlying pathophysiologic mechanisms are poorly understood. We previously showed that 3,4-l-dihydroxylphenyalanine (DOPA) sensitizes vasomotor response to sympathetic tone via coupling between the adrenergic receptor alpha1 (ADRA1) and a G protein-coupled receptor 143 (GPR143), a DOPA receptor. We investigated whether DOPA similarly enhances ADRA1-mediated contraction in pulmonary arteries isolated from rats, and whether GPR143 is involved in the PH pathogenesis. Pretreating the isolated pulmonary arteries with DOPA 1 μM enhanced vasoconstriction in response to phenylephrine, an ADRA1 agonist, but not to U-46619, a thromboxane A2 agonist or endothelin-1. We generated Gpr143 gene-deficient (Gpr143-/y) rats, and confirmed that DOPA did not augment phenylephrine-induced contractile response in Gpr143-/y rat pulmonary arteries. We utilized a rat model of monocrotaline (MCT)-induced PH. In the MCT model, the right ventricular systolic pressure was attenuated in the Gpr143-/y rats than in WT rats. Phenylephrine-induced cell migration and proliferation were also suppressed in Gpr143-/y pulmonary artery smooth muscle cells than in WT cells. Our result suggests that GPR143 is involved in the PH pathogenesis in the rat models of PH.

    DOI: 10.1016/j.jphs.2021.11.008

    PubMed

    researchmap

  • Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection. 国際誌

    Kei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Hirofumi Go, Yutaro Yamaoka, Norihisa Ohtake, Hideaki Kato, Satoshi Ikeda, Takahiro Mihara, Ikuro Matsuba, Naoko Sanno, Masaaki Miyakawa, Masaharu Shinkai, Tomoyuki Miyazaki, Takashi Ogura, Shuichi Ito, Takeshi Kaneko, Kouji Yamamoto, Atsushi Goto, Akihide Ryo

    Open forum infectious diseases   9 ( 2 )   ofab626   2022年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits varying degrees of protective immunity conferred by neutralizing antibodies (nAbs). In this study, we report the persistence of nAb responses over 12 months after infection despite their decreasing trend noticed from 6 months. Methods: The study included sera from 497 individuals who had been infected with SARS-CoV-2 between January and August 2020. Samples were collected at 6 and 12 months after onset. The titers of immunoglobulin (Ig)G to the viral nucleocapsid protein (NP) and receptor-binding domain (RBD) of the spike protein were measured by chemiluminescence enzyme immunoassay. The nAb titer was determined using lentivirus-based pseudovirus or authentic virus. Results: Antibody titers of NP-IgG, RBD-IgG, and nAbs were higher in severe and moderate cases than in mild cases at 12 months after onset. Although the nAb levels were likely to confer adequate protection against wild-type viral infection, the neutralization activity to recently circulating variants in some of the mild cases (~30%) was undermined, implying the susceptibility to reinfection with the variants of concerns (VOCs). Conclusions: Coronavirus disease 2019 convalescent individuals have robust humoral immunity even at 12 months after infection albeit that the medical history and background of patients could affect the function and dynamics of antibody response to the VOCs.

    DOI: 10.1093/ofid/ofab626

    PubMed

    researchmap

  • Epileptic discharges initiate from brain areas with elevated accumulation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors. 査読 国際誌

    Tomoyuki Miyazaki, Yutaro Takayama, Masaki Iwasaki, Mai Hatano, Waki Nakajima, Naoki Ikegaya, Tetsuya Yamamoto, Shohei Tsuchimoto, Hiroki Kato, Takuya Takahashi

    Brain communications   4 ( 2 )   fcac023   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Presurgical identification of the epileptogenic zone is a critical determinant of seizure control following surgical resection in epilepsy. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor is a major component of neurotransmission. Although elevated α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor levels are observed in surgically resected brain areas of patients with epilepsy, it remains unclear whether increased α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor-mediated currents initiate epileptic discharges. We have recently developed the first PET tracer for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, [11C]K-2, to visualize and quantify the density of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors in living human brains. Here, we detected elevated [11C]K-2 uptake in the epileptogenic temporal lobe of patients with mesial temporal lobe epilepsy. Brain areas with high [11C]K-2 uptake are closely colocalized with the location of equivalent current dipoles estimated by magnetoencephalography or with seizure onset zones detected by intracranial electroencephalogram. These results suggest that epileptic discharges initiate from brain areas with increased α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, providing a biological basis for epileptic discharges and an additional non-invasive option to identify the epileptogenic zone in patients with mesial temporal lobe epilepsy.

    DOI: 10.1093/braincomms/fcac023

    PubMed

    researchmap

  • Subanesthetic Dose of Propofol Activates the Reward System in Rats. 国際誌

    Isao Nagata, Mika Sasaki, Tomoyuki Miyazaki, Kensuke Saeki, Ken-Ichi Ogawa, Yoshinori Kamiya

    Anesthesia and analgesia   2021年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Propofol has addictive properties, even with a single administration, and facilitates dopamine secretion in the nucleus accumbens (NAc). Activation of the dopaminergic circuits of the midbrain reward system, including the ventral tegmental area (VTA) and NAc, plays a crucial role in addiction. However, the effects of propofol on synaptic transmission and biochemical changes in the VTA-NAc circuit remain unclear. METHODS: We investigated the effects of subanesthetic doses of propofol on rat VTA neurons and excitatory synaptic transmission in the NAc using slice patch-clamp experiments. Using immunohistochemistry and western blot analyses, we evaluated the effects of intraperitoneal propofol administration on the expression of addiction-associated transcription factor ΔFosB (truncated form of the FBJ murine osteosarcoma viral oncogene homolog B protein) in the NAcs in 5-week-old rats. RESULTS: In the current-clamp mode, a subanesthetic dose (0.5-5 µmol/L) of propofol increased the action potential frequency in about half the VTA neurons (excited neurons: control: 9.4 ± 3.0 Hz, propofol 0.5 µmol/L: 21.5 ± 6.0 Hz, propofol 5 µmol/L: 14.6 ± 5.3 Hz, wash: 2.0 ± 0.7 Hz, n = 14/27 cells; unchanged/suppressed neurons: control: 1.68 ± 0.94 Hz, propofol 0.5 µmol/L: 1.0 ± 0.67 Hz, propofol 5 µmol/L: 0.89 ± 0.87 Hz, wash: 0.16 ± 0.11 Hz, n = 13/27 cells). In the voltage-clamp mode, about half the VTA principal neurons showed inward currents with 5 µmol/L of propofol (inward current neurons: control: -20.5 ± 10.0 pA, propofol 0.5 µmol/L: -62.6 ± 14.4 pA, propofol 5 µmol/L: -85.2 ± 18.3 pA, propofol 50 µmol/L: -17.1 ± 39.2 pA, washout: +30.5 ± 33.9 pA, n = 6/11 cells; outward current neurons: control: -33.9 ± 14.6 pA, propofol 0.5 µmol/L: -29.5 ± 16.0 pA, propofol 5 µmol/L: -0.5 ± 20.9 pA, propofol 50 µmol/L: +38.9 ± 18.5 pA, washout: +40.8 ± 32.1 pA, n = 5/11 cells). Moreover, 0.5 µmol/L propofol increased the amplitudes of evoked excitatory synaptic currents in the NAc, whereas >5 µmol/L propofol decreased them (control: 100.0 ± 2.0%, propofol 0.5 µmol/L: 118.4 ± 4.3%, propofol 5 µmol/L: 98.3 ± 3.3%, wash [within 10 min]: 70.7 ± 3.3%, wash [30 minutes later]: 89.9 ± 2.5%, n = 13 cells, P < .001, Dunnett's test comparing control and propofol 0.5 µmol/L). Intraperitoneally administered subanesthetic dose of propofol increased ΔFosB expression in the NAc, but not in VTA, 2 and 24 hours after administration, compared with the Intralipid control group (propofol 2 hours: 0.94 ± 0.15, 24 hours: 0.68 ± 0.07; Intralipid 2 hours: 0.40 ± 0.03, 24 hours: 0.37 ± 0.06, P = .0002 for drug in the 2-way analysis of variance). CONCLUSIONS: Even a single administration of a subanesthetic dose of propofol may cause rewarding change in the central nervous system. Thus, there is a potential propofol rewarding effect among patients receiving anesthesia or sedation with propofol, as well as among health care providers exposed to propofol.

    DOI: 10.1213/ANE.0000000000005847

    PubMed

    researchmap

  • Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests. 国際誌

    Yutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Rikako Funabashi, Koji Okudela, Sayaka Kikuchi, Junichi Katada, Atsuhiko Wada, Toshiki Takei, Mayuko Nishi, Kohei Shimizu, Hiroki Ozawa, Shuzo Usuku, Chiharu Kawakami, Nobuko Tanaka, Takeshi Morita, Hiroyuki Hayashi, Hideaki Mitsui, Keita Suzuki, Daisuke Aizawa, Yukihiro Yoshimura, Tomoyuki Miyazaki, Etsuko Yamazaki, Tadaki Suzuki, Hirokazu Kimura, Hideaki Shimizu, Nobuhiko Okabe, Hideki Hasegawa, Akihide Ryo

    Cell reports. Medicine   2 ( 6 )   100311 - 100311   2021年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The ongoing coronavirus disease 2019 (COVID-19) pandemic is a major global public health concern. Although rapid point-of-care testing for detecting viral antigen is important for management of the outbreak, the current antigen tests are less sensitive than nucleic acid testing. In our current study, we produce monoclonal antibodies (mAbs) that exclusively react with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and exhibit no cross-reactivity with other human coronaviruses, including SARS-CoV. Molecular modeling suggests that the mAbs bind to epitopes present on the exterior surface of the nucleocapsid, making them suitable for detecting SARS-CoV-2 in clinical samples. We further select the optimal pair of anti-SARS-CoV-2 nucleocapsid protein (NP) mAbs using ELISA and then use this mAb pair to develop immunochromatographic assay augmented with silver amplification technology. Our mAbs recognize the variants of concern (501Y.V1-V3) that are currently in circulation. Because of their high performance, the mAbs of this study can serve as good candidates for developing antigen detection kits for COVID-19.

    DOI: 10.1016/j.xcrm.2021.100311

    PubMed

    researchmap

  • [11C]K-2 image with positron emission tomography represents cell surface AMPA receptors 国際誌

    Tetsu Arisawa, Tomoyuki Miyazaki, Wataru Ota, Akane Sano, Kumiko Suyama, Yuuki Takada, Takuya Takahashi

    Neuroscience Research   173   106 - 113   2021年5月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    The glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) is an important molecule in neurotransmission. We have recently developed the first positron emission tomography (PET) tracer [11C]K-2 to visualize and quantify AMPARs in the living human brain. After injection, [11C]K-2 is hydrolyzed at the terminal amide (and is thus metabolized to a major metabolite, [11C]K-2OH) within 10 min, representing the PET image in rodents and humans. Here, we found that K-2OH did not penetrate the cell membrane but slowly passed through the blood brain barrier (BBB) with paracellular transport. Furthermore, major efflux transporters in the BBB did not carry K-2OH. Logan graphical analysis exhibited reversible binding kinetics of this radiotracer in healthy individuals; these results demonstrated that the PET image of this tracer represents cell surface AMPARs with passive penetration of [11C]K-2OH through the BBB, resulting in reversible binding kinetics. Thus, PET images with this tracer depict the physiologically crucial fraction of AMPARs.

    DOI: 10.1016/j.neures.2021.05.009

    PubMed

    researchmap

  • Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11C]K-2, in healthy human subjects. 国際誌

    Mai Hatano, Tomoyuki Miyazaki, Yoshinobu Ishiwata, Waki Nakajima, Tetsu Arisawa, Yoko Kuroki, Ayako Kobayashi, Yuuki Takada, Matsuyoshi Ogawa, Kazunori Kawamura, Ming-Rong Zhang, Makoto Higuchi, Masataka Taguri, Yasuyuki Kimura, Takuya Takahashi

    Scientific reports   11 ( 1 )   1598 - 1598   2021年1月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    [11C]K-2, a radiotracer exhibiting high affinity and selectivity for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), is suitable for the quantification of AMPARs in living human brains and potentially useful in the identification of epileptogenic foci in patients. This study aimed to estimate the radiation doses of [11C]K-2 in various organs and calculate the effective dose after injection of [11C]K-2 in healthy human subjects. Twelve healthy male subjects were registered and divided into two groups (370 or 555 MBq of [11C]K-2), followed by 2 h whole-body scans. We estimated the radiation dose of each organ and then calculated the effective dose for each subject. The highest uptake of [11C]K-2 was observed in the liver, while the brain also showed relatively high uptake. The urinary bladder exhibited the highest radiation dose. The kidneys and liver also showed high radiation doses after [11C]K-2 injections. The effective dose of [11C]K-2 ranged from 5.0 to 5.2 μSv/MBq. Our findings suggest that [11C]K-2 is safe in terms of the radiation dose and adverse effects. The injection of 370-555 MBq (10 to 15 mCi) for PET studies using this radiotracer is applicable in healthy human subjects and enables serial PET scans in a single subject.

    DOI: 10.1038/s41598-021-81002-3

    PubMed

    researchmap

  • Translational medicine of the glutamate AMPA receptor.

    Tomoyuki Miyazaki, Hiroki Abe, Hiroyuki Uchida, Takuya Takahashi

    Proceedings of the Japan Academy. Series B, Physical and biological sciences   97 ( 1 )   1 - 21   2021年

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Psychiatric and neurological disorders severely hamper patient's quality of life. Despite their high unmet needs, the development of diagnostics and therapeutics has only made slow progress. This is due to limited evidence on the biological basis of these disorders in humans. Synapses are essential structural units of neurotransmission, and neuropsychiatric disorders are considered as "synapse diseases". Thus, a translational approach with synaptic physiology is crucial to tackle these disorders. Among a variety of synapses, excitatory glutamatergic synapses play central roles in neuronal functions. The glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a principal component of glutamatergic neurotransmission; therefore, it is considered to be a promising translational target. Here, we review the limitations of current diagnostics and therapeutics of neuropsychiatric disorders and advocate the urgent need for the promotion of translational medicine based on the synaptic physiology of AMPAR. Furthermore, we introduce our recent translational approach to these disorders by targeting at AMPARs.

    DOI: 10.2183/pjab.97.001

    PubMed

    researchmap

  • CLP290 promotes the sedative effects of midazolam in neonatal rats in a KCC2-dependent manner: A laboratory study in rats. 国際誌

    Akiko Doi, Tomoyuki Miyazaki, Takahiro Mihara, Maiko Ikeda, Ryo Niikura, Tomio Andoh, Takahisa Goto

    PloS one   16 ( 3 )   e0248113   2021年

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Immature neurons dominantly express the Na+-K+-2Cl- cotransporter isoform 1 (NKCC1) rather than the K+-Cl- cotransporter isoform 2 (KCC2). The intracellular chloride ion concentration ([Cl-]i) is higher in immature neurons than in mature neurons; therefore, γ-aminobutyric acid type A (GABAA) receptor activation in immature neurons does not cause chloride ion influx and subsequent hyperpolarization. In our previous work, we found that midazolam, benzodiazepine receptor agonist, causes less sedation in neonatal rats compared to adult rats and that NKCC1 blockade by bumetanide enhances the midazolam-induced sedation in neonatal, but not in adult, rats. These results suggest that GABA receptor activation requires the predominance of KCC2 over NKCC1 to exert sedative effects. In this study, we focused on CLP290, a novel KCC2-selective activator, and found that midazolam administration at 20 mg/kg after oral CLP290 intake significantly prolonged the righting reflex latency even in neonatal rats at postnatal day 7. By contrast, CLP290 alone did not exert sedative effects. Immunohistochemistry showed that midazolam combined with CLP290 decreased the number of phosphorylated cAMP response element-binding protein-positive cells in the cerebral cortex, suggesting that CLP290 reverted the inhibitory effect of midazolam. Moreover, the sedative effect of combined CLP290 and midazolam treatment was inhibited by the administration of the KCC2-selective inhibitor VU0463271, suggesting indirectly that the sedation-promoting effect of CLP290 was mediated by KCC2 activation. To our knowledge, this study is the first report showing the sedation-promoting effect of CLP290 in neonates and providing behavioral and histological evidence that CLP290 reverted the sedative effect of GABAergic drugs through the activation of KCC2. Our data suggest that the clinical application of CLP290 may provide a breakthrough in terms of midazolam-resistant sedation.

    DOI: 10.1371/journal.pone.0248113

    PubMed

    researchmap

  • Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors. 国際誌

    Atsushi Goto, Hirofumi Go, Kei Miyakawa, Yutaro Yamaoka, Norihisa Ohtake, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Takahiro Mihara, Kotaro Senuki, Tomoyuki Miyazaki, Satoshi Ikeda, Takashi Ogura, Hideaki Kato, Ikuro Matsuba, Naoko Sanno, Masaaki Miyakawa, Haruo Ozaki, Masakazu Kikuoka, Yasuo Ohashi, Akihide Ryo, Takeharu Yamanaka

    Frontiers in microbiology   12   661187 - 661187   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Objective: There is scarce evidence regarding the long-term persistence of neutralizing antibodies among coronavirus disease 2019 (COVID-19) survivors. This study determined neutralizing antibody titers (NT50) and antibodies against spike protein (SP) or nucleocapsid protein (NP) antigens approximately 6 months after the diagnosis of COVID-19. Methods: COVID-19 survivors in Japan were recruited. Serum samples and data related to patients' characteristics and COVID-19 history were collected. NT50 and titers of antibodies against NP and SP antigens were measured at 20-32 weeks after the first positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results. Factors associated with NT50 were identified using the multivariable linear regression and the correlations among NT50 and titers of immunoglobulin G (IgG) and total immunoglobulins (Igs) against NP and SP were assessed by Spearman's correlation. Results: Among 376 participants (median [range] days after testing positive for SARS-CoV-2, 180 (147-224); median [range] years of age, 50 (20-78); 188 [50%] male), most tested positive for NT50 (n = 367, 98%), SP-IgG (n = 344, 91%), SP-total Ig (n = 369, 98%), NP-IgG (n = 314, 84%), and NP-total Ig (n = 365, 97%). Regression analysis indicated that higher BMI, fever, and the requirement of mechanical ventilation or extracorporeal membrane oxygenation were significantly associated with higher NT50. Anti-SP antibodies correlated moderately with NT50 (Spearman's correlation: 0.63 for SP IgG; 0.57 for SP-total Ig), while the correlation was weak for anti-NP antibodies (0.37 for NP IgG; 0.32 for NP-total Ig). Conclusions: Most COVID-19 survivors had sustained neutralizing antibodies and tested positive for SP-total Ig and NP-total Ig approximately 6 months after infection.

    DOI: 10.3389/fmicb.2021.661187

    PubMed

    researchmap

  • Exploratory analyses of postanesthetic effects of desflurane using behavioral test battery of mice. 査読 国際誌

    Ryo Niikura, Tomoyuki Miyazaki, Kumiko Yonezaki, Kazuhiro Uchimoto, Kenkichi Takase, Takahisa Goto

    Behavioural pharmacology   31 ( 7 )   597 - 609   2020年5月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Halogenated ethers, such as desflurane, sevoflurane, and isoflurane, are known to exert an array of effects besides sedation. However, the postanesthetic effects of desflurane remain undiscovered as no study has explored these effects systematically. Phenotypic screening using behavioral test batteries is a powerful method to identify such effects. In the present study, we behaviorally phenotyped desflurane-treated mice to investigate postanesthetic effects. We applied comprehensive behavioral test batteries measuring sensorimotor functions, anxiety, depression, sociability, attention, and learning abilities, starting 7 days after anesthesia performed with 8.0% desflurane for 6 h. Although our previous study revealed postanesthetic effects of isoflurane in adult mice, in the current study, desflurane-treated mice exhibited no such effects in any behavioral test. To further examine whether desflurane affect behavior in more early time point, we built up a new additional test battery, which carried out 1 day or 3 days after exposure to desflurane. Mice treated with desflurane 1 day before testing showed more slips than other two groups in the first trial, suggesting mild acute side effects of desflurane on motor coordination. These results suggest the safety of desflurane in clinical settings and imply that postanesthetic effects are unique to each halogenated ether.

    DOI: 10.1097/FBP.0000000000000567

    PubMed

    researchmap

  • Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice. 国際誌

    Hiromichi Wakui, Takahiro Yamaji, Kengo Azushima, Kazushi Uneda, Kotaro Haruhara, Akiko Nakamura, Kohji Ohki, Sho Kinguchi, Ryu Kobayashi, Shingo Urate, Toru Suzuki, Daisuke Kamimura, Shintaro Minegishi, Tomoaki Ishigami, Tomohiko Kanaoka, Kohei Matsuo, Tomoyuki Miyazaki, Tetsuya Fujikawa, Akio Yamashita, Kouichi Tamura

    Scientific reports   10 ( 1 )   1782 - 1782   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Chronic kidney disease (CKD) progresses to end-stage renal failure via renal tubulointerstitial fibrosis. Malnutrition, inflammation, and arteriosclerosis interact to exacerbate the poor prognosis of CKD, and their effective management is thus essential. The traditional Japanese medicine Rikkunshito (RKT) exerts appetite-stimulating effects via ghrelin, which attenuates inflammation and fibrosis. We evaluated the therapeutic effect of RKT in unilateral ureter obstruction (UUO)-induced renal fibrosis/inflammation and body weight loss in mice. UUO and sham-operated mice were fed a standard diet or diet containing 3.0% RKT. Renal fibrosis was investigated by histopathology and macrophage infiltration was determined by immunohistochemistry. Expression levels of genes associated with fibrosis, inflammation, ghrelin, and mitochondrial function were determined by quantitative reverse transcription-polymerase chain reaction and western blot analyses. RKT treatment partially prevented UUO-induced weight loss but failed to attenuate renal fibrosis and inflammation. Renal expression of sirtuin 1, a ghrelin-downstream signalling molecule, and gene expression of peroxisome proliferator-activated receptor-γ coactivator 1α and Bcl-2/adenovirus E1B interacting protein 3 were unaffected by RKT. These results indicate that RKT inhibits weight loss but does not improve renal fibrosis or inflammation in a rapidly progressive renal fibrosis mouse model. RKT may have a protective effect on weight loss associated with CKD.

    DOI: 10.1038/s41598-020-58214-0

    PubMed

    researchmap

  • Visualization of AMPA receptors in living human brain with positron emission tomography. 査読 国際誌

    Nature Medicine   26 ( 2 )   281 - 288   2020年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/s41591-019-0723-9

    PubMed

    researchmap

  • Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies 国際誌

    Ueno F, Suzuki T, Nakajima S, Matsushita S, Mimura M, Miyazaki T, Takahashi T, Uchida H

    Neuropsychopharmacology Reports   39 ( 3 )   148 - 155   2019年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Neuropsychopharmacology Reports  

    © 2019 The Authors. Neuropsychopharmacology Reports published by John Wiley &amp; Sons Australia, Ltd. Background and Objectives: Altered trafficking of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors has been reported in postmortem studies and suggested the involvement of AMPA receptors in the pathophysiology underpinning addictive disorders. However, these findings seemed mixed. Methods: A systematic literature search was conducted, using PubMed and Embase (last search, August 2018), to identify human postmortem studies that examined the expression of proteins and mRNA of AMPA receptor subunits in patients with addictive disorders in comparison with healthy controls. Results: Twelve (18 studies) out of 954 articles were identified to be relevant. Eight studies included alcohol use disorders, and four studies included heroin/cocaine abusers. The most frequently investigated regions were the hippocampus (three studies), amygdala (three studies), and putamen (three studies). In summary, two out of the three studies showed an increase in the expression of AMPA receptors in the hippocampus, while the other study found no change. Two studies to examine the amygdal

    DOI: 10.1002/npr2.12058

    PubMed

    researchmap

  • Short-term fasting decreases excitatory synaptic inputs to ventromedial tuberoinfundibular dopaminergic neurons and attenuates their activity in male mice 査読 国際誌

    Takafumi Kubota, Atsushi Fukushima, Hiroko Hagiwara, Yoshinori Kamiya, Miyako Furuta, Tomoyuki Miyazaki, Hitomi Fujioka, Sei-Etsu Fujiwara, Toshiya Funabashi, Tatsuo Akema

    Neuroscience Letters   671   70 - 75   2018年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier Ireland Ltd  

    Tuberoinfundibular dopaminergic (TIDA) neurons in the arcuate nucleus (ARC) of the hypothalamus play a role in inhibiting prolactin (PRL) secretion from the anterior pituitary. PRL is involved in a variety of behaviors, including feeding. Consequently, we hypothesized that fasting might reduce the activity of TIDA neurons, which might alter PRL secretion. However, direct examinations of TIDA neuron activity are difficult. Recently, transgenic mice were generated that expressed green fluorescent protein (GFP) under the control of the rat tyrosine hydroxylase gene. We first determined that GFP in the dorsomedial ARC was a reliable marker of TIDA neurons. Then, we performed electrophysiology and immunocytochemistry in GFP-labeled TIDA neurons to examine whether different feeding conditions could change their activity. Eight-week-old male mice were fed or fasted for 24 h. After sacrifice, we prepared acutely isolated brain slices for conducting whole-cell voltage-clamp recordings. TIDA neurons were identified with fluorescence microscopy. The mean amplitude of miniature excitatory postsynaptic currents (mEPSCs) was significantly reduced in fasting mice compared to fed mice, but different feeding conditions did not affect the mean mEPSC intervals. This result suggested that fasting reduced the number of excitatory synaptic inputs to TIDA neurons. To determine whether a reduction in excitatory synaptic inputs would cause a reduction in TIDA neuron activity, we examined the effect of 24-h fasting on c-Fos expression in the ARC. We found that fasting significantly reduced the number of Fos-positive TIDA neurons. In addition, serum PRL levels were significantly increased. Taken together, the present findings suggested that short-term fasting attenuated TIDA neuron activity.

    DOI: 10.1016/j.neulet.2018.02.017

    Scopus

    PubMed

    researchmap

  • Comparison between High- and Low-Cost Transmission of Tele-Anesthesia in Japan. 査読 国際誌

    Yoh Sugawara, Tetsuya Miyashita, Yusuke Mizuno, Yusuke Nagamine, Tomoyuki Miyazaki, Ayako Kobayashi, Kentaro Tojo, Yasuhiro Iketani, Shunsuke Takaki, Takahisa Goto

    Journal of healthcare engineering   2018   9615264 - 9615264   2018年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: We previously reported a tele-anesthesia system that connected Sado General Hospital (SGH) to Yokohama City University Hospital (YCUH) using a dedicated virtual private network (VPN) that guaranteed the quality of service. The study indicated certain unresolved problems, such as the high cost of constantly using a dedicated VPN for tele-anesthesia. In this study, we assessed whether use of a best-effort system affects the safety and cost of tele-anesthesia in a clinical setting. Methods: One hundred patients were enrolled in this study. We provided tele-anesthesia for 65 patients using a guaranteed transmission system (20 Mbit/s; guaranteed, 372,000 JPY per month: 1 JPY = US$0.01) and for 35 patients using a best-effort system (100 Mbit/s; not guaranteed, 25,000 JPY per month). We measured transmission speed and number of commands completed from YCUH to SGH during tele-anesthesia with both transmission systems. Results: In the guaranteed system, anesthesia duration was 5780 min (88.9 min/case) and surgical duration was 3513 min (54.0 min/case). In the best-effort system, anesthesia duration was 3725 min (106.4 min/case) and surgical duration was 2105 min (60.1 min/case). The average transmission speed in the best-effort system was 17.3 ± 3.8 Mbit/s. The system provided an acceptable delay time and frame rate in clinical use. All commands were completed, and no adverse events occurred with both systems. Discussion: In the field of tele-anesthesia, using a best-effort internet VPN system provided equivalent safety and efficacy at a better price as compared to using a guaranteed internet VPN system.

    DOI: 10.1155/2018/9615264

    PubMed

    researchmap

  • Social isolation suppresses actin dynamics and synaptic plasticity through ADF/cofilin inactivation in the developing rat barrel cortex 査読 国際誌

    Hirobumi Tada, Tomoyuki Miyazaki, Kiwamu Takemoto, Susumu Jitsuki, Waki Nakajima, Mayu Koide, Naoko Yamamoto, Akiko Taguchi, Honami Kawai, Kasane Komiya, Kumiko Suyama, Hiroki Abe, Akane Sano, Takuya Takahashi

    SCIENTIFIC REPORTS   7 ( 1 )   8471 - 8471   2017年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Exposure to a stressful environment early in life can cause psychiatric disorders by disrupting circuit formation. Actin plays central roles in regulating neuronal structure and protein trafficking. We have recently reported that neonatal isolation inactivated ADF/cofilin, the actin depolymerizing factor, resulted in a reduced actin dynamics at spines and an attenuation of synaptic alpha-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid (AMPA) receptor delivery in the juvenile rat medial prefrontal cortex (mPFC), leading to altered social behaviours. Here, we investigated the impact of neonatal social isolation in the developing rat barrel cortex. Similar to the mPFC study, we detected an increase in stable actin fraction in spines and this resulted in a decreased synaptic AMPA receptor delivery. Thus, we conclude that early life social isolation affects multiple cortical areas with common molecular changes.

    DOI: 10.1038/s41598-017-08849-3

    Web of Science

    PubMed

    researchmap

  • Mechanisms of POD and POCD: Effects of anesthetics 査読

    Tomoyuki Miyazaki, Yoshikazu Yamaguchi, Takahisa Goto

    Anesthesia and Neurotoxicity   133 - 150   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:論文集(書籍)内論文   出版者・発行元:Springer Japan  

    Postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) worsen quality of life in postoperative patients and, moreover, impose huge cost on hospitals. Previous clinical reports revealed that POD appears to be a risk for high mortality in the elderly and POCD appears to have long-lasting adverse effect on learning performance in children. Nevertheless nobody has proposed the effective way to cure them. We are still struggling in exploring mechanisms underlying POD and POCD because of the following reasons: (1) clinical definitions may be obscure, (2) underlying mechanisms are multifactorial, (3) less animal models comparable with patients are available. Under these difficulties, a considerable number of studies have contributed to identify key molecules and neural circuits essential for the establishment of these diseases and fortunately some of them appear to postulate reliable mechanisms. Integrating latest findings, here we discuss about these mechanisms underlying POD and POCD.

    DOI: 10.1007/978-4-431-55624-4_9

    Scopus

    researchmap

  • Neonatal isolation augments social dominance by altering actin dynamics in the medial prefrontal cortex 査読 国際誌

    Hirobumi Tada, Tomoyuki Miyazaki, Kiwamu Takemoto, Kenkichi Takase, Susumu Jitsuki, Waki Nakajima, Mayu Koide, Naoko Yamamoto, Kasane Komiya, Kumiko Suyama, Akane Sano, Akiko Taguchi, Takuya Takahashi

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   113 ( 45 )   E7097 - E7105   2016年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    Social separation early in life can lead to the development of impaired interpersonal relationships and profound social disorders. However, the underlying cellular and molecular mechanisms involved are largely unknown. Here, we found that isolation of neonatal rats induced glucocorticoid-dependent social dominance over nonisolated control rats in juveniles from the same litter. Furthermore, neonatal isolation inactivated the actin-depolymerizing factor (ADF)/cofilin in the juvenile medial prefrontal cortex (mPFC). Isolation-induced inactivation of ADF/cofilin increased stable actin fractions at dendritic spines in the juvenile mPFC, decreasing glutamate synaptic AMPA receptors. Expression of constitutively active ADF/cofilin in the mPFC rescued the effect of isolation on social dominance. Thus, neonatal isolation affects spines in the mPFC by reducing actin dynamics, leading to altered social behavior later in life.

    DOI: 10.1073/pnas.1606351113

    Web of Science

    PubMed

    researchmap

  • Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice 査読 国際誌

    Haruko Nakamura, Naoya Yamashita, Ayuko Kimura, Yayoi Kimura, Hisashi Hirano, Hiroko Makihara, Yuko Kawamoto, Aoi Jitsuki-Takahashi, Kumiko Yonezaki, Kenkichi Takase, Tomoyuki Miyazaki, Fumio Nakamura, Fumiaki Tanaka, Yoshio Goshima

    GENES TO CELLS   21 ( 10 )   1059 - 1079   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Collapsin response mediator protein 2 (CRMP2) plays a key role in axon guidance, dendritic morphogenesis and cell polarization. CRMP2 is implicated in various neurological and psychiatric disorders. However, invivo functions of CRMP2 remain unknown. We generated CRMP2 gene-deficient (crmp2(-/-)) mice and examined their behavioral phenotypes. During 24-h home cage monitoring, the activity level during the dark phase of crmp2(-/-) mice was significantly higher than that of wild-type (WT) mice. Moreover, the time during the open arm of an elevated plus maze was longer for crmp2(-/-) mice than for WT mice. The duration of social interaction was shorter for crmp2(-/-) mice than for WT mice. Crmp2(-/-) mice also showed mild impaired contextual learning. We then examined the methamphetamine-induced behavioral change of crmp2(-/-) mice. Crmp2(-/-) mice showed increased methamphetamine-induced ambulatory activity and serotonin release. Crmp2(-/-) mice also showed altered expression of proteins involved in GABAergic synapse, glutamatergic synapse and neurotrophin signaling pathways. In addition, SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization, are also decreased in crmp2(-/-) mice. Our study implies that dysregulation of CRMP2 may be involved in pathophysiology of neuropsychiatric disorders.

    DOI: 10.1111/gtc.12403

    Web of Science

    PubMed

    researchmap

  • Bumetanide, an Inhibitor of NKCC1 (Na-K-2Cl Cotransporter Isoform 1), Enhances Propofol-Induced Loss of Righting Reflex but Not Its Immobilizing Actions in Neonatal Rats 査読 国際誌

    Yukihide Koyama, Tomio Andoh, Yoshinori Kamiya, Tomoyuki Miyazaki, Koichi Maruyama, Takayuki Kariya, Takahisa Goto

    PLOS ONE   11 ( 10 )   e0164125   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Gamma-aminobutyric acid (GABA) has been shown to induce excitation on immature neurons due to increased expression of Na+-K+-2Cl-co-transporter isoform 1 (NKCC1), and the transition of GABAergic signaling from excitatory to inhibitory occurs before birth in the rat spinal cord and spreads rostrally according to the developmental changes in cationchloride co-transporter expression. We previously showed that midazolam activates the hippocampal CA3 area and induces less sedation in neonatal rats compared with adolescent rats in an NKCC1-dependent manner. In the present study, we tested the hypothesis that propofol-induced loss of righting reflex (LORR) but not immobilizing actions are modulated by NKCC1-dependent mechanisms and reduced in neonatal rats compared with adolescent rats. We estimated neuronal activity in the cortex, hippocampus and thalamus after propofol administration with or without bumetanide, an NKCC1 inhibitor, by immunostaining of phosphorylated cyclic adenosine monophosphate-response element binding protein (pCREB). We studied effects of bumetanide on propofol-induced LORR and immobilizing actions in postnatal day 7 and 28 (P7 and P28) rats. The pCREB expression in the cortex (P = 0.001) and hippocampus (P = 0.01) was significantly greater in the rats receiving propofol only than in the rats receiving propofol plus bumetanide at P 7. Propofol-induced LORR or immobilizing effects did not differ significantly between P7 and P28. Bumetanide significantly enhanced propofol-induced LORR (P = 0.031) but not immobilization in P7 rats. These results are partially consistent with our hypothesis. They suggest that propofol may activate the rostral but not caudal central nervous system dependently on NKCC1, and these differential actions may underlie the different properties of sedative and immobilizing actions observed in neonatal rats.

    DOI: 10.1371/journal.pone.0164125

    Web of Science

    PubMed

    researchmap

  • Fear Conditioning Induced by Interpersonal Conflicts in Healthy Individuals 査読 国際誌

    Mitsuhiro Tada, Hiroyuki Uchida, Takaki Maeda, Mika Konishi, Satoshi Umeda, Yuri Terasawa, Shinichiro Nakajima, Masaru Mimura, Tomoyuki Miyazaki, Takuya Takahashi

    PLOS ONE   10 ( 5 )   e0125729   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Psychophysiological markers have been focused to investigate the psychopathology of psychiatric disorders and personality subtypes. In order to understand neurobiological mechanisms underlying these conditions, fear-conditioning model has been widely used. However, simple aversive stimuli are too simplistic to understand mechanisms because most patients with psychiatric disorders are affected by social stressors. The objective of this study was to test the feasibility of a newly-designed conditioning experiment using a stimulus to cause interpersonal conflicts and examine associations between personality traits and response to that stimulus. Twenty-nine healthy individuals underwent the fear conditioning and extinction experiments in response to three types of stimuli: a simple aversive sound, disgusting pictures, and pictures of an actors' face with unpleasant verbal messages that were designed to cause interpersonal conflicts. Conditioned response was quantified by the skin conductance response (SCR). Correlations between the SCR changes, and personality traits measured by the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) and Revised NEO Personality Inventory were explored. The interpersonal conflict stimulus resulted in successful conditioning, which was subsequently extinguished, in a similar manner as the other two stimuli. Moreover, a greater degree of conditioned response to the interpersonal conflict stimulus correlated with a higher ZAN-BPD total score. Fear conditioning and extinction can be successfully achieved, using interpersonal conflicts as a stimulus. Given that conditioned fear caused by the interpersonal conflicts is likely associated with borderline personality traits, this paradigm could contribute to further understanding of underlying mechanisms of interpersonal fear implicated in borderline personality disorder.

    DOI: 10.1371/journal.pone.0125729

    Web of Science

    PubMed

    researchmap

  • A pilot study of tele-anaesthesia by virtual private network between an island hospital and a mainland hospital in Japan 査読 国際誌

    Tetsuya Miyashita, Yusuke Mizuno, Yo Sugawara, Yusuka Nagamine, Yukihide Koyama, Tomoyuki Miyazaki, Kazuhiro Uchimoto, Yasuhiro Iketani, Kentaro Tojo, Takahisa Goto

    JOURNAL OF TELEMEDICINE AND TELECARE   21 ( 2 )   73 - 79   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SAGE PUBLICATIONS LTD  

    We studied the use of tele-anaesthesia between Sado General Hospital (SGH) located on Sado Island and Yokohama City University Hospital (YCUH) located in mainland Japan. The two sites were connected via a virtual private network (VPN). We investigated the relationship between the bandwidth of the VPN and both the frame rate and the delay time of the tele-anaesthesia monitoring system. The tool used for communication between the two hospitals was free videoconferencing software (FaceTime), which can be used over Wi-Fi connections. We also investigated the accuracy of the commands given during teleanaesthesia: any commands from the anaesthetist at the YCUH that were not carried out for any reason, were recorded in the anaesthetic records at the SGH. The original frame rate and data rate at the SGH were 5fps and approximately 18 Mbit/s, respectively. The frame rate at the transmission speeds of 1, 5 and 20 Mbit/s was 0.6, 1.6 and 5.0fps, respectively. The corresponding delay time was 12.2, 4.9 and 0.7s. Twenty-five adult patients were enrolled in the study and tele-anaesthesia was performed. The total duration of anaesthesia was 37 hours. All 888 anaesthetic commands were completed. There were 7 FaceTime disconnections, which lasted for 10min altogether. Because no commands needed to be given during the FaceTime disconnection, the telephone was not used. The anaesthesia assistance system might form part of the solution to medical resource shortages.

    DOI: 10.1177/1357633X14562735

    Web of Science

    PubMed

    researchmap

  • Postanesthetic Effects of Isoflurane on Behavioral Phenotypes of Adult Male C57BL/6J Mice 査読 国際誌

    Kumiko Yonezaki, Kazuhiro Uchimoto, Tomoyuki Miyazaki, Ayako Asakura, Ayako Kobayashi, Kenkichi Takase, Takahisa Goto

    PLOS ONE   10 ( 3 )   e0122118   2015年3月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Isoflurane was previously the major clinical anesthetic agent but is now mainly used for veterinary anesthesia. Studies have reported widespread sites of action of isoflurane, suggesting a wide array of side effects besides sedation. In the present study, we phenotyped isoflurane-treated mice to investigate the postanesthetic behavioral effects of isoflurane. We applied comprehensive behavioral test batteries comprising sensory test battery, motor test battery, anxiety test battery, depression test battery, sociability test battery, attention test battery, and learning test battery, which were started 7 days after anesthesia with 1.8% isoflurane. In addition to the control group, we included a yoked control group that was exposed to the same stress of handling as the isoflurane-treated animals before being anesthetized. Our comprehensive behavioral test batteries revealed impaired latent inhibition in the isoflurane-treated group, but the concentration of residual isoflurane in the brain was presumably negligible. The yoked control group and isoflurane-treated group exhibited higher anxiety in the elevated plus-maze test and impaired learning function in the cued fear conditioning test. No influences were observed in sensory functions, motor functions, antidepressant behaviors, and social behaviors. A number of papers have reported an effect of isoflurane on animal behaviors, but no systematic investigation has been performed. To the best of our knowledge, this study is the first to systematically investigate the general health, neurological reflexes, sensory functions, motor functions, and higher behavioral functions of mice exposed to isoflurane as adults. Our results suggest that the postanesthetic effect of isoflurane causes attention deficit in mice. Therefore, isoflurane must be used with great care in the clinical setting and veterinary anesthesia.

    DOI: 10.1371/journal.pone.0122118

    Web of Science

    PubMed

    researchmap

  • Isoflurane Impairs Learning and Hippocampal Long-term Potentiation via the Saturation of Synaptic Plasticity 査読 国際誌

    Kazuhiro Uchimoto, Tomoyuki Miyazaki, Yoshinori Kamiya, Takahiro Mihara, Yukihide Koyama, Masataka Taguri, Gaku Inagawa, Takuya Takahashi, Takahisa Goto

    ANESTHESIOLOGY   121 ( 2 )   302 - 310   2014年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Background: General anesthesia induces long-lasting cognitive and learning deficits. However, the underlying mechanism remains unknown. The GluA1 subunit of AMPAR is a key molecule for learning and synaptic plasticity, which requires trafficking of GluA1-containing AMPARs into the synapse.
    Methods: Adult male rats were exposed to 1.8% isoflurane for 2 h and subjected to an inhibitory avoidance task, which is a hippocampus-dependent contextual fear learning paradigm (n = 16 to 39). The in vitro extracellular field potential of hippocampal synapses between the Schaffer collateral and the CA1 was evaluated using a multielectrode recorder (n = 6 per group). GluA1 expression in the synaptoneurosome was assessed using Western blotting (n = 5 to 8). The ubiquitination level of GluA1 was evaluated using immunoprecipitation and Western blotting (n = 7 per group).
    Results: Seven days after exposure to 1.8% isoflurane for 2 h (Iso(1.8)), the inhibitory avoidance learning (control vs. Iso(1.8); 294 +/- 34 vs. 138 +/- 28, the mean +/- SEM [%]; P = 0.002) and long-term potentiation (125.7 +/- 6.1 vs. 105.7 +/- 3.3; P &lt; 0.001) were impaired. Iso(1.8) also temporarily increased GluA1 in the synaptoneurosomes (100 +/- 9.7 vs. 138.9 +/- 8.9; P = 0.012) and reduced the GluA1 ubiquitination, a main degradation pathway of GluA1 (100 +/- 8.7 vs. 71.1 +/- 6.1; P = 0.014).
    Conclusions: Isoflurane impairs hippocampal learning and modulates synaptic plasticity in the postanesthetic period. Increased GluA1 may reduce synaptic capacity for additional GluA1-containing AMPARs trafficking.

    DOI: 10.1097/ALN.0000000000000269

    Web of Science

    PubMed

    researchmap

  • Very short exposure of volatile anesthetics induces long-term learning deficit in young adult male rats

    Kazuhiro Uchimoto, H. Fujimoto, K. Yonezaki, T. Miyazaki, T. Ando, T. Goto

    EUROPEAN JOURNAL OF ANAESTHESIOLOGY   31   121 - 121   2014年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(その他学術会議資料等)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Role of nerve growth factor-tyrosine kinase receptor A signaling in paclitaxel-induced peripheral neuropathy in rats 査読 国際誌

    Yusuke Nakahashi, Yoshinori Kamiya, Kengo Funakoshi, Tomoyuki Miyazaki, Kazuhiro Uchimoto, Kentaro Tojo, Kenichi Ogawa, Tetsuo Fukuoka, Takahisa Goto

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   444 ( 3 )   415 - 419   2014年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    The mechanisms underlying paclitaxel-induced peripheral neuropathy remain unknown. Nerve growth factor (NGF) is a representative neurotrophic factor that maintains neuronal function, promotes survival, and mediates neuropathic pain. We investigated expression levels of NGF and its receptors in the dorsal root ganglia (DRG) and spinal dorsal horn (DH) following paclitaxel treatment. Intraperitoneal (I.P.) administration of paclitaxel induced significant mechanical hypersensitivity and cold allodynia in rats, significantly increased the expression of NGF and its receptor tyrosine kinase receptor A (trkA) in the DRG, and increased NGF expression in the DH. In contrast, paclitaxel treatment did not alter the mRNA levels of NGF or its receptors in the DRG, DH, sciatic nerve, or hindpaw skin. Moreover, expression of NEDD4-2, a negative regulator of trkA, was significantly increased in the DRG of paclitaxel-treated rats. Intrathecal (I.T.) administration of the tyrosine kinase receptor inhibitor k252a significantly alleviated mechanical hypersensitivity in paclitaxel-treated rats. Our results suggest that NGF-trkA signaling is involved in mechanical allodynia in paclitaxel-induced neuropathy. (C) 2014 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2014.01.082

    Web of Science

    PubMed

    researchmap

  • Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits γ-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats. 査読 国際誌

    Koyama Y, Andoh T, Kamiya Y, Morita S, Miyazaki T, Uchimoto K, Mihara T, Goto T

    Anesthesiology   119 ( 5 )   1096 - 1108   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1097/ALN.0b013e31829e4b05

    Scopus

    PubMed

    researchmap

  • Comparison of postoperative learning deficit due to isoflurane exposure or propofol infusion

    Uchimoto K, Miyazaki T, Kamiya Y, Tominaga Y, Goto T

    European Journal of Anaesthesiology   30   109 - 110   2013年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(その他学術会議資料等)  

    researchmap

  • Social isolation perturbs experience-driven synaptic glutamate receptor subunit 4 delivery in the developing rat barrel cortex 査読 国際誌

    Tomoyuki Miyazaki, Misako Kunii, Susumu Jitsuki, Akane Sano, Yoshiyuki Kuroiwa, Takuya Takahashi

    EUROPEAN JOURNAL OF NEUROSCIENCE   37 ( 10 )   1602 - 1609   2013年5月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    In neonates, the stress of social isolation can alter developing neural circuits and cause mental illness. However, the molecular and cellular bases for these effects are poorly understood. Experience-driven synaptic AMPA receptor delivery is crucial for circuit organisation during development. In the rat, whisker experience drives the delivery of glutamate receptor subunit 4 (GluA4) but not glutamate receptor subunit 1 (GluA1) to layer 42/3 pyramidal synapses in the barrel cortex during postnatal day (P)810, whereas GluA1 but not GluA4 is delivered to these synapses during P1214. We recently reported that early social isolation disrupts experience-driven GluA1 delivery to layer 42/3 pyramidal synapses during P1214. Here, we report that neonatal isolation affects even earlier stages of development by preventing experience-dependent synaptic GluA4 delivery. Thus, social isolation severely affects synaptic maturation throughout early postnatal development.

    DOI: 10.1111/ejn.12188

    Web of Science

    PubMed

    researchmap

  • Disrupted cortical function underlies behavior dysfunction due to social isolation 査読 国際誌

    Tomoyuki Miyazaki, Kenkichi Takase, Waki Nakajima, Hirobumi Tada, Daisuke Ohya, Akane Sano, Takahisa Goto, Hajime Hirase, Roberto Malinow, Takuya Takahashi

    JOURNAL OF CLINICAL INVESTIGATION   122 ( 7 )   2690 - 2701   2012年7月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC CLINICAL INVESTIGATION INC  

    Stressful events during early childhood can have a profound lifelong influence on emotional and cognitive behaviors. However, the mechanisms by which stress affects neonatal brain circuit formation are poorly understood. Here, we show that neonatal social isolation disrupts molecular, cellular, and circuit developmental processes, leading to behavioral dysfunction. Neonatal isolation prevented long-term potentiation and experience-dependent synaptic trafficking of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors normally occurring during circuit formation in the rodent barrel cortex. This inhibition of AMPA receptor trafficking was mediated by an increase of the stress glucocorticoid hormone and was associated with reduced calcium/calmodulin-dependent protein kinase type II (CaMKII) signaling, resulting in attenuated whisker sensitivity at the cortex. These effects led to defects in whisker-dependent behavior in juvenile animals. These results indicate that neonatal social isolation alters neuronal plasticity mechanisms and perturbs the initial establishment of a normal cortical circuit, which potentially explains the long-lasting behavioral effects of neonatal stress.

    DOI: 10.1172/JCI63060

    Web of Science

    PubMed

    researchmap

  • Developmental AMPA receptor subunit specificity during experience-driven synaptic plasticity in the rat barrel cortex 査読 国際誌

    Tomoyuki Miyazaki, Misako Kunii, Hirobumi Tada, Akane Sano, Yoshiyuki Kuroiwa, Takahisa Goto, Roberto Malinow, Takuya Takahashi

    BRAIN RESEARCH   1435   1 - 7   2012年1月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    During early postnatal brain development, experience-driven delivery of AMPA receptors to synapses participates in the initial organization of conical function. By combining virus-mediated in vivo gene delivery with in vitro whole cell recordings, we identified a subunit-specific developmental program of experience-driven AMPA receptor delivery to synapses in rat barrel cortex. We expressed green fluorescent protein (GFP)-tagged AMPA receptors (GFP-GluR1, or GFP-GluR4) into layer 2/3 pyramidal neurons at two distinct developmental periods, postnatal day (P)8-P10 and P12-P14. Two days after viral infection, acute brain slices were prepared, and synaptic transmission from layer 4 to layer 2/3 was analyzed by whole cell recordings. We found that whisker experience drives GluR4 but not GluR1 into these synapses early in postnatal development (P8-1310). However, at P12-14, GluR1 but not GluR4 is delivered into synapses by whisker experience. This precise developmental plan suggests unique plasticity properties endowed in different AMPA receptor subunits which shape the initial experience-driven organization of cortical function. (C) 2011 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.brainres.2011.11.033

    Web of Science

    PubMed

    researchmap

  • Intrathecally administered Sema3A protein attenuates neuropathic pain behavior in rats with chronic constriction injury of the sciatic nerve 査読 国際誌

    Michiko Hayashi, Yoshinori Kamiya, Hideki Itoh, Tomoko Higashi, Tomoyuki Miyazaki, Kengo Funakoshi, Naoya Yamashita, Yoshio Goshima, Tomio Andoh, Yoshitsugu Yamada, Takahisa Goto

    NEUROSCIENCE RESEARCH   69 ( 1 )   17 - 24   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    Semaphorins, one of the repulsive axonal guidance factors during development, are produced under pathological conditions in adult animals. In the neuropathic pain state associated with peripheral nerve injury, synaptic reorganization occurs in spinal cord dorsal horn. In the present study, we investigated the roles of intrathecal administration of Sema3A, a secreted semaphorin, in the spinal cord of chronic constriction injury (CCI) model rat. Neuropilin 1 (NPR1) and Plexin A (PlexA), co-receptors of Sema3A, were expressed in the dorsal horn of naive rats. NPR1, and not PlexA, protein expression increased in the dorsal spinal cord of CCI rats. Recombinant Sema3A protein attenuated mechanical allodynia and heat hyperalgesia in CCI rats, whereas heat-inactivated Sema3A had no effect. Immunohistochemistry revealed that Sema3A partially restored the decrease of isolectin B4-positive unmyelinated nerve terminals in lamina II of the ipsilateral dorsal horn of CCI rats. Contrary to our expectations. Sema3A did not change the distribution of myelinated fibers in lamina II at 7 days after CCI. Those results suggested that the suppressive role for Sema3A in the development of neuropathic pain associated with peripheral nerve injury in adult rats, which seemed to be independent from prevention of the myelinated fiber sprouting into lamina II. (C) 2010 Elsevier Ireland Ltd and the japan Neuroscience Society. All rights reserved.

    DOI: 10.1016/j.neures.2010.09.006

    Web of Science

    PubMed

    researchmap

▼全件表示

書籍等出版物

  • Anesthesia and Neurotoxicology

    宮崎 智之( 担当: 共著 範囲: POD and POCD)

    Springer Japan  2017年 

     詳細を見る

MISC

  • てんかん診療 てんかんにおけるAMPA受容体の可視化

    宮崎智之, 阿部弘基, 高橋琢哉

    月刊脳神経内科   96 ( 5 )   2022年

     詳細を見る

  • 「治療抵抗性うつ病に対するケタミン作用機序の探索 AMPA受容体PET研究」の研究プロトコールの紹介

    内田 裕之, 大谷 洋平, 谷 英明, 三村 將, 宮崎 智之, 高橋 琢哉

    日本うつ病学会総会・日本認知療法・認知行動療法学会プログラム・抄録集   18回・21回   373 - 373   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本うつ病学会・日本認知療法・認知行動療法学会  

    researchmap

  • 11C標識新規トレーサーによるAMPA受容体の定量画像化のための臨床プロトコル

    木村 裕一, 山田 誉大, 波多野 真衣, 中島 和希, 宮崎 智之, 高橋 琢哉

    核医学   56 ( Suppl. )   S162 - S162   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本核医学会  

    researchmap

  • 11C標識新規トレーサーによるLoganグラフィカル法を用いたAMPA受容体の定量画像化

    木村 裕一, 宮崎 智之, 高橋 琢哉

    核医学   55 ( Suppl. )   S167 - S167   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本核医学会  

    researchmap

  • Disrupted cortical function underlies behavior dysfunction due to social isolation (vol 122, pg 2690, 2012)

    Tomoyuki Miyazaki, Kenkichi Takase, Waki Nakajima, Hirobumi Tada, Daisuke Ohya, Akane Sano, Takahisa Goto, Hajime Hirase, Roberto Malinow, Takuya Takahashi

    JOURNAL OF CLINICAL INVESTIGATION   124 ( 6 )   2807 - 2807   2014年6月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER SOC CLINICAL INVESTIGATION INC  

    DOI: 10.1172/JCI76901

    Web of Science

    researchmap

  • B-53 マーモセットにおける経験依存的AMPA 受容体シナプス移行の観察

    高橋 琢哉, 実木 亨, 多田 敬典, 宮崎 智之

    霊長類研究所年報   43   107 - 107   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:京都大学霊長類研究所  

    CiNii Books

    researchmap

  • Mechanisms underlying disruption of cortical function by neonatal isolation

    Tomoyuki Miyazaki, Kenkichi Takase, Hirobumi Tada, Akane Sano, Daisuke Oya, Waki Nakajima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   71   E323 - E324   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1413

    Web of Science

    researchmap

  • 乳仔期ストレスによる皮質機能障害のメカニズム(Mechanisms underlying disruption of cortical function by neonatal isolation)

    宮崎 智之, 高瀬 堅吉, マリナウ・ロバート, 高橋 琢哉

    神経化学   49 ( 2-3 )   500 - 500   2010年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • Mechanisms underlying disruption of cortical function by neonatal isolation

    Tomoyuki Miyazaki, Kenkichi Takase, Malinow Roberto, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E88 - E88   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.155

    Web of Science

    researchmap

  • LOCALIZATION OF BRAIN REGION RESPONSIVE TO NEONATAL SOCIAL ISOLATION

    Hiroki Matsuki, Taisuke Kawasaki, Tomoyuki Miyazaki, Toshiya Funabashi, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   518 - 518   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:SPRINGER TOKYO  

    Web of Science

    researchmap

  • SEX DIFFERENCE OF THE EFFECT OF NEONATAL SOCIAL ISOLATION ON EXPERIENCE DRIVEN SYNAPTIC DELIVERY OF AMPA RECEPTORS IN RAT BARREL CORTEX

    Hirobumi Tada, Tomoyuki Miyazaki, Kasane Komiya, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   135 - 135   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:SPRINGER TOKYO  

    Web of Science

    researchmap

  • SOCIAL ISOLATION PRODUCES GLUCOCORTICOID-MEDIATED DISRUPTION OF CORTICAL CIRCUIT FORMATION

    Tomoyuki Miyazaki, Kenkichi Takase, Hirobumi Tada, Dai Mitsushima, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   366 - 366   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Sex difference of the effect of neonatal social isolation on experience driven synaptic delivery of AMPA receptors in rat barrel cortex

    Hirobumi Tada, Tomoyuki Miyazaki, Kasane Komiya, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S42 - S42   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.051

    Web of Science

    researchmap

  • Social isolation produces glucocorticoid-mediated disruption of cortical circuit formation

    Tomoyuki Miyazaki, Kenkichi Takase, Hirobumi Tada, Dai Mitsushima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S58 - S58   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.156

    Web of Science

    researchmap

  • 経験依存的AMPA受容体シナプス移行(Experience dependent synaptic delivery of AMPA receptors)

    宮崎 智之, 多田 敬典, 美津島 大, 高橋 琢也

    神経化学   47 ( 2-3 )   222 - 222   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • Social isolation disrupts experience-driven synaptic delivery of AMPA receptors in developing rat barrel cortex via glucocorticoid

    Tomoyuki Miyazaki, Kenkichi Takase, Dai Mitsushima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   61   S60 - S60   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

▼全件表示

講演・口頭発表等

  • Visualization of AMPA receptors in living human brain with positron emission tomography - the novel approach to delineate epileptic focus 国際会議

    宮崎 智之

    WCP2018  2018年7月 

     詳細を見る

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • AMPA受容体の基礎的知見と臨床応用への可能性 招待

    宮﨑智之

    第41回日本臨床麻酔学会大会  2021年11月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • AMPA受容体量の増加を指標とした内側側頭葉てんかん患者におけるてんかん原性領域の可視化

    宮﨑智之

    第44回日本神経科学大会  2021年7月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(公募)  

    researchmap

  • 多角的モダリティを用いた神経伝達物質の生理・病態生理学的意義の解明

    宮﨑智之

    第95回日本薬理学会年会  2022年3月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(公募)  

    researchmap

  • 麻酔薬の新規効能を探索する基礎研究の試み 招待

    宮﨑智之

    第24回日本神経麻酔集中治療学会  2020年8月 

     詳細を見る

    会議種別:口頭発表(招待・特別)  

    researchmap

  • 基礎および臨床研究をつなぐ双方向的アプローチから見えてくるAMPA受容体の中心的役割

    宮﨑智之

    第43回日本神経科学大会  2020年8月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(公募)  

    researchmap

  • 麻酔科領域における脳科学研究の将来展望 招待

    宮﨑智之

    第68回日本麻酔科学会学術集会  2021年6月 

     詳細を見る

    会議種別:口頭発表(招待・特別)  

    researchmap

  • 新規PET薬剤を用いた生体脳内でのAMPA受容体のダイナムズムの可視化

    宮﨑智之

    第94回日本薬理学会年会  2021年3月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(公募)  

    researchmap

  • (放射性標識)新規AMPA受容体PETイメージング製剤によるてんかん焦点同定の補助診断薬としての臨床開発 招待

    宮﨑智之

    第5回橋渡し研究戦略的推進プログラムシンポジウム  2020年2月 

     詳細を見る

    会議種別:口頭発表(招待・特別)  

    researchmap

  • 基礎医学研究における心理学研究者の潜在的フィールドの紹介‐麻酔科学を中心として‐ 招待

    宮﨑智之

    日本心理学会第82回大会  2018年9月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • New Antidepressant Drug of AMPA positive allosteric modulators 国際会議

    宮崎 智之

    WCP2018  2018年7月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • AMPA受容体をターゲットとした新規抗うつ薬の開発

    宮崎 智之

    第138回日本薬理学会関東部会  2018年3月 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

▼全件表示

産業財産権

受賞

  • 山村記念賞

    2024年6月   日本麻酔科学会   麻酔薬の治療薬・診断薬としての応用可能性

     詳細を見る

  • 横浜市立大学医学会賞

    2021年5月  

    宮﨑智之

     詳細を見る

  • 横浜市立大学学長賞

    2020年3月  

    宮﨑智之

     詳細を見る

  • 学長表彰

    2018年3月   横浜市立大学  

    宮崎 智之

     詳細を見る

共同研究・競争的資金等の研究課題

  • 新たな治療法の開発に向けたパニック症におけるAMPA受容体脳画像研究

    研究課題/領域番号:24K09684  2024年4月 - 2029年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    浅見 剛, 宮崎 智之, 高石 政男

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    researchmap

  • 治療抵抗性うつ病にも有効な新規即効性抗うつ薬の開発

    2022年5月 - 2024年3月

    AMED  橋渡し研究プログラム 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 薬剤抵抗性てんかんの外科治療成績を向上させる頭蓋内脳波解析アルゴリズムの開発

    研究課題/領域番号:22K09296  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    岩崎 真樹, 小野 弓絵, 宮崎 智之

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    researchmap

  • AMPA受容体密度を指標とした慢性疼痛患者の痛み定量化バイオマーカー開発研究

    2021年5月 - 2024年3月

    AMED  慢性の痛み解明研究事業 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • AMPA受容体に着目した新規疼痛バイオマーカーの創出

    2021年 - 2025年

    中冨健康科学振興財団  研究助成 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • AMPA受容体密度変化に基づく精神疾患症状に対応するモデル動物の作製と神経回路の同定

    2021年 - 2023年

    大日本住友製薬  PRISM 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • AMPA受容体異常に着目した統合失調症モデル動物の解析

    2021年 - 2022年

    上原記念生命科学財団  研究助成 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 治療抵抗性うつ病に対するケタミン効果発現の神経基盤の解明

    2020年 - 2025年

    武田科学振興財団  生命科学研究助成 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 創薬とその臨床応用に関する研究

    2020年 - 2021年

    持田記念医学薬学振興財団  研究助成 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • AMPA受容体PETイメージングを利用した機能回復ネットワークの解明

    研究課題/領域番号:19H03980  2019年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    阿部 弘基, 宮崎 智之, 高田 薫子, 齊藤 勇二

      詳細を見る

    配分額:16770000円 ( 直接経費:12900000円 、 間接経費:3870000円 )

    2020年度前半は、2019年度にまとめた亜急性期脳梗塞患者6例のリハビリテーション過程におけるAMPA PETの画像解析結果を特定臨床研究の総括報告書にまとめる作業を行った。この総括報告書は2021年2月に横浜市立大学臨床研究審査委員会で審議・承認され正式に終了した。2020年度後半はパーキンソン病におけるAMPA受容体PETイメージングの研究計画の立案を開始した。パーキンソン病は病理学的には中脳黒質緻密部ドーパミン神経細胞の変性脱落が観察されるが、症候学的には振戦が前景となる症例もあれば、運動緩慢や筋強剛が前景となる症例も存在する。前景となる症状に応じて疾患進行程度も異なり、振戦が目立つ症例は歩行障害や姿勢反射障害の進行が緩徐であるが、初期から姿勢反射障害や歩行障害が目立つと進行が早い。ドーパミン神経細胞の変性脱落という一様な病理にも関わらず、前景となる症状は多様であり疾患の進行度合いも異なる。この多様性を特徴付ける生物学的指標は現在存在しない。モデル動物研究では、ドーパミン欠乏によって線条体有棘ニューロン(SPN)のグルタミン酸興奮性伝達のバランスが破綻することが知られている。薬理学的研究では、線条体有棘ニューロンのうち、D2受容体を発現するニューロンのAMPA受容体を拮抗すると運動症状が改善することが知られている。これらの先行研究調査を動機として、本研究課題ではあらためて、ドーパミン産生神経細胞の減少が線条体における興奮性グルタミン酸AMPA受容体の発現密度にどのような変化をもたらすのかを探索することを目的とした。本研究計画は特定臨床臨床研究として2021年3月に承認された(jRCTs031200448)。

    researchmap

  • てんかん外科を革新する異常神経回路同定法の構築

    研究課題/領域番号:19K09494  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    岩崎 真樹, 土岐 圭伊子, 飯島 圭哉, 宮崎 智之

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    手術中に麻酔をかけた状態で記録される脳波を解析することで、てんかんの原因となっている脳の領域を診断する方法を開発した。8名の難治てんかん患者を対象に麻酔中の脳波の高周波・徐波位相カップリングを解析したところ、麻酔薬の濃度が最大に達する直前においててんかんの原因部位ではカップリングが特に大きくなることが分かった。特定の麻酔条件下で脳波の高周波・徐波位相カップリングを解析することにより、てんかんの原因領域を手術中に短時間で診断できる可能性が示唆された。

    researchmap

  • 敗血症モデルへの層別化メタボローム解析に基づくPICSメカニズム解明と治療法探索

    研究課題/領域番号:19H03753  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    後藤 隆久, 宮崎 智之, 杉浦 悠毅, 新倉 怜, 高瀬 堅吉, 東條 健太郎

      詳細を見る

    配分額:17420000円 ( 直接経費:13400000円 、 間接経費:4020000円 )

    本研究の目標はラットを用いた敗血症後の中枢神経系post-ICU syndrome PICSモデルを構築し,脳における網羅的な代謝産物解析を行うことで,敗血症後の中枢神経PICSの病態メカニズム,新規治療法を探索することであった。2021年度より長期的に炎症が継続する敗血症モデルとして盲腸結紮穿刺(CLP)モデルを作成し,2週間後に Inhibitory Avoidanceテストを行った上で,血中のサイトカイン濃度を調べたところ,若年ラットの敗血症では,脳の炎症が回復期の行動実験の成績悪化と関連している可能性が示唆されたが,中枢神経への大きな影響は観察されなかった。
    これを踏まえ,当該年度には中枢神経ではなく,身体的PICSのモデル構築,解析を行う方針に切り替え研究を行った。最初にCLPモデルマウスを用いて,2週間後までの運動機能について評価を行った結果,自発運動機能はある程度改善したものの,ワイヤーハングテストにおける握力の低下が継続しており,また協調運動機能も低下している傾向が見られた。一方で,筋断面積については明らかな低下は見られず,機能的な原因で筋力の低下が起きている可能性が示唆された。また,急性期における筋肉の代謝変化を見るためにLPS誘導性ショックモデルにおける筋肉のメタボローム解析を行ったところ,異化亢進に加え,ケトン体の増加やアセチルカルニチン/カルニチン比の低下といった代謝障害を示唆する結果が得られた。以上から,若年マウスを用いた敗血症モデルにおいては急性期に異化亢進,代謝障害が生じ,機能不全を主因とする筋力低下が生じることが示唆された。

    researchmap

  • AMPA受容体標的とした新規抗うつ薬の開発

    2017年 - 2018年

    AMED  橋渡し研究プログラム 

    宮﨑智之

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • メタボロミクスによる傷害肺のエネルギー代謝の包括的解明と治療応用に向けた基盤研究

    研究課題/領域番号:16K11414  2016年10月 - 2020年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    太田 周平, 東條 健太郎, 宮崎 智之, 馬場 靖子

      詳細を見る

    配分額:4810000円 ( 直接経費:3700000円 、 間接経費:1110000円 )

    本研究では最初に肺胞上皮細胞培養をLPS活性化好中球によって傷害を引き起こすin vitro実験系を構築し,傷害を受けた肺胞上皮細胞のエネルギー代謝が大きく変化することを見出した.マイクロアレイを用いて傷害をうけた細胞のトランスクリプトームを解析したところ,インスリン抵抗性経路に変化が見られ,エネルギー代謝の変化に関係している可能性が示唆された.これを踏まえ,インスリンシグナルを阻害したところ,肺胞上皮細胞の傷害を抑制することができたことから,インスリン抵抗性経路は肺傷害の治療標的になりうる可能性があると考えられた.

    researchmap

  • AMPA受容体PETプローブを用いた精神神経疾患横断的研究

    2016年5月 - 2021年3月

    日本医療研究開発機構  脳科学研究戦略推進プログラム 

    高橋 琢哉

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 幼若動物の鎮静耐性におけるカリウム-塩素イオン共輸送担体の機能解析と治療法開発

    研究課題/領域番号:16K10945  2016年4月 - 2020年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    安藤 富男, 宮崎 智之

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    CLP290を投与することで細胞内の塩素イオンが細胞外にくみ出され、相対的に細胞外の塩素イオン濃度が高くなる。今回の研究では、細胞内塩素イオン濃度を規定するKCC2のリン酸化をCLP290が上昇させることが分かった。この状態でGABA受容体作動薬を投与すると、GABA受容体の活性化に引き続き、濃度が高い細胞外から塩素イオンが細胞内に流入し、神経細胞の活性化が抑制される。本研究ではこの現象をpCREBを用いた免疫組織学的検討により明らかにした。こうした細胞生物学的変化は、個体レベルにおいては鎮静を引き起こすことが明らかになった。本研究では、この現象を正向反射を用いて検討した。

    researchmap

  • セボフルランによる抗不安効果発現の神経回路同定とその分子メカニズムの解明

    2016年4月 - 2019年3月

    文部科学省  基盤研究B 

    後藤 隆久

      詳細を見る

    資金種別:競争的資金

    researchmap

  • オピオイドの新規効能を応用したPTSD治療法の開発

    2016年4月 - 2018年3月

    文部科学省  挑戦的萌芽研究 

    宮崎 智之

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 性別、発達段階に応じたライフステージ依存性麻酔後効果の検討

    研究課題/領域番号:16K15678  2016年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業  挑戦的萌芽研究

    後藤 隆久, 宮崎 智之, 高瀬 堅吉

      詳細を見る

    配分額:3510000円 ( 直接経費:2700000円 、 間接経費:810000円 )

    申請者らは、吸入麻酔薬が高次脳機能に対して示す曝露後の効果に着目し、網羅的行動テストバッテリーを組み合わせて検討してきた。本課題では発達段階に応じたライフステージ依存性麻酔後効果の検討を実施した。アルツハイマー型認知症のモデル(APP-KI)および高齢マウスを用いて検証したところ、APP-KIでは多動、低不安(外界への認知力の低下)が見られたが、デスフルランの投与で多動が軽度抑制された。しかしながら総じてAPP-KIに対してデスフルランの影響は認められなかった。

    researchmap

  • 新規AMPA受容体標識PET薬剤によるてんかん焦点同定の補助診断薬としての開発

    2016年4月 - 2017年3月

    日本医療研究開発機構  橋渡し研究加速ネットワークプログラム 

    高橋 琢哉

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 吸入麻酔薬曝露後の記憶学習能に関するメカニズムの網羅的解析

    研究課題/領域番号:15K10517  2015年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    伊奈川 岳, 後藤 隆久, 内本 一宏, 宮崎 智之, 水原 敬洋, 朝倉 彩子

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    若年雄性Sprague-Dawleyラットにデスフルラン(0.7および1.2 MAC)で2時間麻酔した場合,1.2 MAC群で,対照群と比較し,曝露1日目に海馬依存性文脈的記憶学習の障害を認めたのに対し,0.7 MACでは認めなかった.また曝露後3日目おおよび7日目には学習障害を認めなかった.曝露1日目に1.2 MAC群では対照群と比較し,海馬LTPも抑制され,IA刺激によるGluR1発現も抑制されていた.
    以上より,若年成体ラットに比較的濃度の高いデスフルラン曝露をすると,AMPA受容体のtrafficking が阻害され,曝露1日後に可逆的な記憶学習障害を生じることを認めた.

    researchmap

  • 網羅的行動テストバッテリーを用いた麻酔薬の新規効能探索

    研究課題/領域番号:25293330  2013年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    後藤 隆久, 宮﨑 智之, 内本 一宏, 高瀬 堅吉

      詳細を見る

    配分額:18330000円 ( 直接経費:14100000円 、 間接経費:4230000円 )

    麻酔薬の中枢神経作用には、鎮静と言う主作用だけでなく、術後認知機能の低下など有害な副作用があることが知られている。これら副作用は、手術麻酔という状況から離れれば、臨床応用性を備えた主作用に転じる可能性を有している。本研究では、麻酔曝露を経験したマウスに網羅的行動テストバッテリーを課し、麻酔薬が脳高次機能に与える影響を検討した。その結果①イソフルランでは注意機能が障害される一方で、②デスフルランでは行動異常を誘導しなかった。また③セボフルランは抗不安作用を有することがわかった。

    researchmap

  • 全身麻酔後の記憶学習能変化とAMPA型グルタミン酸受容体の関与に関する研究

    研究課題/領域番号:24592308  2012年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    伊奈川 岳, 後藤 隆久, 内本 一宏, 高橋 琢哉, 宮崎 智之, 富永 洋介, 朝倉 彩子, 弓場 由紀, 米崎 久美子, 足立 明子

      詳細を見る

    配分額:5330000円 ( 直接経費:4100000円 、 間接経費:1230000円 )

    本研究では、成体ラットに対する2時間の臨床用量のイソフルラン曝露によって,その遠隔期(麻酔薬曝露の数日後以降)に,空間認知を含む文脈依存的な記憶学習が障害され,海馬長期増強が抑制されることが示された.さらに海馬GluA1の再取り込み後のユビキチン結合が阻害される一方で、シナプスGluA1が過剰発現しており,シナプスの飽和現象が生じてAMAP受容体のtraffickingが抑制されている可能性が示唆された。またプロポフォール投与ではこれらの海馬の機能障害を認めなかったことから、術後認知記憶障害のリスク因子としては、吸入麻酔薬暴露が大きな要因を占めている可能性が示唆された。

    researchmap

  • 神経障害性疼痛モデル動物におけるシナプス可塑性の解析

    研究課題/領域番号:24791610  2012年4月 - 2014年3月

    日本学術振興会  科学研究費助成事業  若手研究(B)

    宮崎 智之, 紙谷 義孝

      詳細を見る

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    SNL術後早期に、脊髄後角第II層においてpCREBの一時的な低下が生じ、7日目以降正常化する。この変化を調べるため、GAD67-GFPマウスを使用して解析を行ったところ、有意差は認めなかったものの、抑制性神経に強くpCREBの発現を認めた。この現象はCCIモデルでも同様に確認された。このことから、SNL術後早期には、抑制性の神経細胞の活動性が低下することで、興奮性細胞の相対的な活性化が生じ、その結果疼痛閾値が低下するのではないかと推察された。その後、in vivoパッチを立ち上げることに成功し、マウス右後肢を筆で刺激することによってEPSCが増強する範囲を記録した。

    researchmap

▼全件表示

その他

  • 特定臨床研究(研究代表医師として)

     詳細を見る

    1. 健常人を対象とした放射性リガンド[11C]K-2の有効性および安全性を検討する臨床試験、UMIN000020975

    2. 難治性てんかんに対する前側頭葉切除手術症例を対象とした放射性リガンド[11C]K-2の有効性を検討する臨床試験、UMIN000025090

    3. 疾患横断的診断法の開発における放射性リガンド[11C]K-2の有効性をうつ病、双極性障害、統合失調症、依存症、ASD、てんかん、FTD症例と健常人で比較検討するパイロット試験、UMIN000025132

    4. 脳梗塞回復期患者のリハビリテーションによる機能回復過程における[11C]K-2の有効性の探索的臨床試験、UMIN000029952

    5. 放射性リガンド[11C]K-2 を用いたてんかん患者における AMPA 受容体発現量測定を目的とした疫学的臨床試験、UMIN000031624

    6. 精神病ハイリスク症例におけるその後の発病の有無とAMPA受容体密度の関連:[11C]K-2を用いた縦断的PET研究、jRCTs031190151

    7. 自閉症スペクトラム障害患者におけるAMPA受容体密度の検討:[11C]K-2を用いた横断PET研究、jRCTs031190149

    8. うつ病および双極性障害患者におけるAMPA受容体密度の検討:[11C]K-2を用いた横断PET研究、jRCTs031190150

    9. 統合失調症患者におけるAMPA受容体密度の検討:[11C]K-2を用いた横断PET研究、jRCTs031190197

    10. 健常者における加齢および性別に伴うAMPA受容体密度変化の検討:[11C]K-2を用いた横断PET研究、jRCTs031200083

    11. アンジェルマン症候群患者に対するAMPA-PETおよびGABA-PETを用いた病態解明研究、jRCTs031210261

    12. AMPA受容体密度を指標とした慢性疼痛患者における痛み定量化のバイオマーカー開発研究、jRCTs031210314

    researchmap

  • 医師主導治験(治験責任医師として)

     詳細を見る

    1. 成人健常男性を対象とした放射性リガンド[11C]K-2合成装置を用いた[11C]K-2の実効線量及び安全性を検討する臨床試験(医師主導治験)、UMIN000026357

    2. 焦点切除術を検討する難治性てんかん患者を対象としたAMPA-PET検査のてんかん焦点診断における有効性を検討する探索的治験(医師主導治験)、JapicCTI-194576

    3. T-817MA の臨床第Ⅱ相試験(T817MAJP201R試験)に登録された被験者を対象としたリハビリテーションによる機能回復過程におけるAMPA-PETの有効性を評価する医師主導治験、JapicCTI-194711

    researchmap